https://virtual.ispe.org/p/s/challenges-and-opportunities-in-the-manufacturing-of-new-treatment-modalities-39
https://virtual.ispe.org/p/s/planning-building-and-operating-cell-and-gene-therapy-46
https://virtual.ispe.org/p/s/pharma-40-what-it-is-what-it-isnt-51
https://virtual.ispe.org/p/s/planning-building-and-operating-cell-and-gene-therapy-56
https://virtual.ispe.org/p/s/application-of-ich-q12-principles-in-modern-cmc-submissions-61
https://virtual.ispe.org/p/s/cell-and-gene-therapy-cmc-and-manufacturing-66
https://virtual.ispe.org/p/s/technology-advancements-for-drug-product-manufacturing-71
https://virtual.ispe.org/p/s/increased-automation-and-digitalization-in-manufacturing-76
https://virtual.ispe.org/p/s/practical-challenges-with-quality-system-management-81
https://virtual.ispe.org/p/s/automation-robotics-and-digitalization-in-qc-labs-86
https://virtual.ispe.org/p/s/single-use-technology-strategies-91
https://virtual.ispe.org/p/s/preparing-for-the-workforce-needs-in-biopharma-manufacturing-96
https://virtual.ispe.org/p/s/challenges-and-opportunities-in-the-manufacturing-of-new-treatment-modalities-101
https://virtual.ispe.org/p/s/regulatory-updates-on-biotechnological-and-biologic-products-106
https://virtual.ispe.org/p/s/innovation-in-technological-platforms-in-biopharmaceutical-manufacturing-111
https://virtual.ispe.org/p/s/regulatory-and-industry-insights-and-lessons-learned-116
https://virtual.ispe.org/p/s/a-new-decade-for-continuous-manufacturing-136
https://virtual.ispe.org/p/s/current-status-on-cm-for-biologics-development-to-clinical-141
https://virtual.ispe.org/p/s/success-stories-from-small-molecule-drug-product-146
https://virtual.ispe.org/p/s/implementation-approaches-for-large-molecule-151
https://virtual.ispe.org/p/s/emerging-technologies-156
https://virtual.ispe.org/p/s/analytics-considerations-for-continuous-manufacturing-161
https://virtual.ispe.org/p/s/advances-in-continuous-manufacturing-for-small-molecule-166
https://virtual.ispe.org/p/s/perspectives-on-the-adoption-and-implementation-171
https://virtual.ispe.org/p/s/expert-roundtable-176
https://virtual.ispe.org/p/s/continuous-manufacturing-for-emergency-preparedness-and-rapid-response-accelerating-widespread-adoption-181
https://virtual.ispe.org/p/s/networking-discussion-groups-on-hot-topics-1367
https://virtual.ispe.org/p/s/executive-forum-trends-in-supply-chain-visibility-and-control-part-1-1699
https://virtual.ispe.org/p/s/opening-plenary-quality-and-compliance-ich-q10q12-and-risk-mitigation-1704
https://virtual.ispe.org/p/s/supply-chain-visibility-and-control-part-i-1709
https://virtual.ispe.org/p/s/cleaning-validation-and-cross-contamination-control-1714
https://virtual.ispe.org/p/s/supply-chain-and-cleaning-validation-q-and-a-discussion-1719
https://virtual.ispe.org/p/s/supply-chain-visibility-and-control-drug-shortages-part-ii-1724
https://virtual.ispe.org/p/s/out-of-specifications-oos-investigations-1729
https://virtual.ispe.org/p/s/supply-chain-and-oos-q-and-a-discussion-1734
https://virtual.ispe.org/p/s/data-integrity-in-quality-systems-and-automated-technology-1739
https://virtual.ispe.org/p/s/aseptic-processing-design-operations-and-controls-1744
https://virtual.ispe.org/p/s/regulatory-and-industry-panel-supply-chain-quality-and-compliance-issues-in-the-wake-of-the-covid-19-pandemic-1749
https://virtual.ispe.org/p/s/opening-plenary-1791
https://virtual.ispe.org/p/s/regulatory-updates-on-biotechnological-and-biological-products-1796
https://virtual.ispe.org/p/s/innovation-in-technological-platforms-in-biopharmaceutical-1801
https://virtual.ispe.org/p/s/regulatory-and-industry-insights-and-lessons-learned-1806
https://virtual.ispe.org/p/s/expo-exhibit-showcaseposter-presentations-1811
https://virtual.ispe.org/p/s/inhouse-covid-19-testing-1942
https://virtual.ispe.org/p/s/case-study-fully-automated-robotic-filling-of-atmps-2312
https://virtual.ispe.org/p/s/welcome-to-ispe-europe-virtual-annual-conference-2020-2368
https://virtual.ispe.org/p/s/ispe-in-europe-mission-vision-strategy-2373
https://virtual.ispe.org/p/s/quality-40-2462
https://virtual.ispe.org/p/s/executive-forum-case-study-report-outs-and-panel-discussion-part-4-2491
https://virtual.ispe.org/p/s/twelve-biggest-capa-opportunities-2499
https://virtual.ispe.org/p/s/supply-chain-security-in-times-of-crisis-2504
https://virtual.ispe.org/p/s/developing-a-comprehensive-sustainable-supply-chain-visibility-and-control-strategy-2509
https://virtual.ispe.org/p/s/control-strategies-and-risk-mitigation-2514
https://virtual.ispe.org/p/s/lessons-learned-responding-to-covid-19-2519
https://virtual.ispe.org/p/s/regulatory-trends-on-cleaning-validation-case-studies-2524
https://virtual.ispe.org/p/s/drug-security-integrity-and-recalls-2529
https://virtual.ispe.org/p/s/regulatory-trends-2534
https://virtual.ispe.org/p/s/data-integrity-considerations-for-automated-systems-2539
https://virtual.ispe.org/p/s/regulatory-expectations-and-trends-in-aseptic-processing-review-of-recent-findings-2544
https://virtual.ispe.org/p/s/executive-forum-trends-in-supply-chain-visibility-and-control-part-2-2761
https://virtual.ispe.org/p/s/case-study-1-unexpected-health-crisis-2791
https://virtual.ispe.org/p/s/case-study-2-responding-to-a-cyber-security-breach-2796
https://virtual.ispe.org/p/s/case-study-3-drug-shortage-scenario-2801
https://virtual.ispe.org/p/s/case-study-4-drug-shortage-scenario-2806
https://virtual.ispe.org/p/s/case-study-5-dealing-with-cmos-2811
https://virtual.ispe.org/p/s/foya-category-winner-presentations-3081
https://virtual.ispe.org/p/cf/the-global-pharmaceutical-manufacturing-leadership-forum-fall-2020-meeting-3137
https://virtual.ispe.org/p/s/networking-lounge-exhibits-in-the-partner-showcase-and-foya-displays-open-3278
https://virtual.ispe.org/p/s/networking-lounge-exhibits-in-the-partner-showcase-and-foya-displays-open-3288
https://virtual.ispe.org/p/s/networking-lounge-exhibits-in-the-partner-showcase-and-foya-displays-open-3293
https://virtual.ispe.org/p/s/networking-lounge-exhibits-in-the-partner-showcase-and-foya-displays-open-3308
https://virtual.ispe.org/p/s/networking-lounge-exhibits-in-the-partner-showcase-and-foya-displays-open-3314
https://virtual.ispe.org/p/s/executive-forum-case-study-breakout-discussions-part-3-3321
https://virtual.ispe.org/p/s/plant-tour-abec-3331
https://virtual.ispe.org/p/s/plant-tour-vetter-pharma-fertigung-gmbh-and-co-kg-3336
https://virtual.ispe.org/p/s/welcome-3343
https://virtual.ispe.org/p/s/opening-remarks-3348
https://virtual.ispe.org/p/s/manufacturing-autologous-ex-vivo-genetically-modified-cell-therapies-have-challenges-but-the-future-is-bright-3353
https://virtual.ispe.org/p/s/fireside-chat-3358
https://virtual.ispe.org/p/s/closing-remarks-3363
https://virtual.ispe.org/p/s/welcome-and-opening-remarks-3368
https://virtual.ispe.org/p/s/international-agency-introductions-3373
https://virtual.ispe.org/p/s/regulatory-panel-and-audience-discussion-with-q-and-a-3378
https://virtual.ispe.org/p/s/closing-remarks-3383
https://virtual.ispe.org/p/s/welcome-and-introductions-3388
https://virtual.ispe.org/p/s/andover-clinical-manufacturing-facility-project-3393
https://virtual.ispe.org/p/s/q-and-a-with-panelists-and-session-closing-3398
https://virtual.ispe.org/p/s/welcome-and-introductions-3403
https://virtual.ispe.org/p/s/q-and-a-with-panelists-and-session-closing-3413
https://virtual.ispe.org/p/s/welcome-and-introductions-3418
https://virtual.ispe.org/p/s/cell-and-gene-therapy-in-the-city-of-brotherly-love-3423
https://virtual.ispe.org/p/s/design-and-operational-considerations-for-atmp-manufacturing-facilities-3428
https://virtual.ispe.org/p/s/welcome-and-introductions-3438
https://virtual.ispe.org/p/s/trimming-the-it-quality-management-system-to-do-more-in-pharma-40-3443
https://virtual.ispe.org/p/s/big-data-analytics-for-parenteral-container-system-optimization-and-pharmaceutical-capping-processes-3448
https://virtual.ispe.org/p/s/leveraging-pharma-40-solutions-in-facilities-management-3453
https://virtual.ispe.org/p/s/welcome-and-introductions-3458
https://virtual.ispe.org/p/s/grassroots-innovation-at-amgen-3463
https://virtual.ispe.org/p/s/the-diffusion-of-innovation-management-in-pharma-3468
https://virtual.ispe.org/p/s/mercks-diginnovate-initiative-3473
https://virtual.ispe.org/p/s/welcome-and-introductions-3478
https://virtual.ispe.org/p/s/use-of-cfd-to-evaluate-spray-drying-scale-up-approaches-3483
https://virtual.ispe.org/p/s/using-dynamic-pid-tuning-to-optimize-bioreactor-operations-3488
https://virtual.ispe.org/p/s/recycling-options-for-single-use-biomanufacturing-materials-3493
https://virtual.ispe.org/p/s/update-on-cders-quality-management-maturity-program-3498
https://virtual.ispe.org/p/s/quality-system-maturity-from-a-data-perspective-and-the-maturity-performance-link-3503
https://virtual.ispe.org/p/s/advancing-pharmaceutical-quality-ispes-quality-management-framework-3508
https://virtual.ispe.org/p/s/welcome-and-introductions-3513
https://virtual.ispe.org/p/s/suitability-of-blow-fill-seal-containers-for-vaccines-3518
https://virtual.ispe.org/p/s/welcome-and-introductions-3523
https://virtual.ispe.org/p/s/improving-vaccine-delivery-to-the-developing-world-3528
https://virtual.ispe.org/p/s/project-management-best-practices-in-delivering-cell-and-gene-therapy-facilities-3533
https://virtual.ispe.org/p/s/welcome-and-introductions-3538
https://virtual.ispe.org/p/s/gamp-plus-csa-1-plus-1-equal-3-3543
https://virtual.ispe.org/p/s/complex-simple-devices-3548
https://virtual.ispe.org/p/s/vendor-20-how-to-enable-pharma-40-3553
https://virtual.ispe.org/p/s/welcome-and-introductions-3558
https://virtual.ispe.org/p/s/high-level-retention-strategy-3563
https://virtual.ispe.org/p/s/welcome-and-introductions-3568
https://virtual.ispe.org/p/s/using-data-analytics-to-drive-business-outcomes-in-manufacturing-successfully-3573
https://virtual.ispe.org/p/s/lower-the-barrier-by-raising-the-bar-deployment-of-data-analytics-to-build-an-infrastructure-to-support-continuous-manufacturing-3578
https://virtual.ispe.org/p/s/analytics-keys-to-pharmaceutical-manufacturing-gateways-3583
https://virtual.ispe.org/p/s/shifting-the-focus-to-predictive-and-prescriptive-analytics-3588
https://virtual.ispe.org/p/s/welcome-and-introductions-3593
https://virtual.ispe.org/p/s/creating-process-understanding-and-a-process-control-strategy-that-pass-regulatory-scrutiny-3598
https://virtual.ispe.org/p/s/a-complex-tech-transfer-case-study-3603
https://virtual.ispe.org/p/s/quality-management-maturity-analytics-and-preliminary-results-3608
https://virtual.ispe.org/p/s/deployment-of-a-global-benchmarking-study-and-the-benefits-of-independent-3rd-party-assessment-3613
https://virtual.ispe.org/p/s/welcome-and-introductions-3618
https://virtual.ispe.org/p/s/developing-scientifically-an-assessment-for-a-global-quality-study-methodology-deployment-and-outcome-3623
https://virtual.ispe.org/p/s/aseptic-vaccine-fillfinish-with-bfs-technology-3628
https://virtual.ispe.org/p/s/welcome-and-introductions-3633
https://virtual.ispe.org/p/s/welcome-and-introductions-3638
https://virtual.ispe.org/p/s/welcome-and-introductions-3648
https://virtual.ispe.org/p/s/panel-discussion-3653
https://virtual.ispe.org/p/s/business-rules-and-metrics-designed-to-detect-di-problems-3658
https://virtual.ispe.org/p/s/fda-perspective-on-data-integrity-3663
https://virtual.ispe.org/p/s/welcome-and-introductions-3668
https://virtual.ispe.org/p/s/digital-twin-end-to-end-performance-and-compliance-in-pharma-3673
https://virtual.ispe.org/p/s/nextgen-tech-transfers-for-solids-drug-product-with-modeling-and-pat-3678
https://virtual.ispe.org/p/s/gsks-approach-to-industry-40-with-a-focus-on-digital-process-3683
https://virtual.ispe.org/p/s/considerations-for-multi-product-facilities-in-cgt-what-weve-learned-by-examining-how-to-do-it-all-in-one-building-3688
https://virtual.ispe.org/p/s/application-of-closed-systems-in-advanced-facilities-of-multi-modal-manufacturing-3693
https://virtual.ispe.org/p/s/welcome-and-introductions-3698
https://virtual.ispe.org/p/s/minimize-downtime-and-maximize-growth-no-matter-what-the-market-holds-3703
https://virtual.ispe.org/p/s/evolving-global-combination-product-regulations-an-industry-perspective-3708
https://virtual.ispe.org/p/s/precision-dosing-considerations-geometry-of-containers-filling-process-and-parameters-container-device-interface-3713
https://virtual.ispe.org/p/s/welcome-and-introductions-3718
https://virtual.ispe.org/p/s/evolving-global-combination-product-regulations-an-industry-perspective-3723
https://virtual.ispe.org/p/s/rapid-quality-notification-system-3728
https://virtual.ispe.org/p/s/welcome-and-introductions-3733
https://virtual.ispe.org/p/s/business-continuity-management-at-a-global-pharmaceutical-company-3738
https://virtual.ispe.org/p/s/fda-drug-shortages-update-3743
https://virtual.ispe.org/p/s/ispe-drug-shortage-initiative-team-3748
https://virtual.ispe.org/p/s/paradigm-shift-in-the-execution-of-capex-projects-3753
https://virtual.ispe.org/p/s/welcome-and-introductions-3758
https://virtual.ispe.org/p/s/beyond-flash-track-facility-delivery-in-a-time-of-crisis-3763
https://virtual.ispe.org/p/s/speed-up-clean-utilities-execution-with-modularization-3768
https://virtual.ispe.org/p/s/welcome-and-introductions-3773
https://virtual.ispe.org/p/s/cryptographic-measures-to-reinforce-data-integrity-3778
https://virtual.ispe.org/p/s/blockchain-pharma-industry-update-3783
https://virtual.ispe.org/p/s/innovative-medicines-initiative-imi-pharmaledger-project-3788
https://virtual.ispe.org/p/s/applying-phase-appropriate-gmps-to-develop-and-deliver-of-atmps-3793
https://virtual.ispe.org/p/s/welcome-and-introductions-3798
https://virtual.ispe.org/p/s/digital-design-and-operation-in-the-pharmaceutical-industry-3803
https://virtual.ispe.org/p/s/welcome-and-introductions-3808
https://virtual.ispe.org/p/s/modelling-complex-variability-sources-measured-by-a-multi-tiered-test-for-an-inhalation-powder-3813
https://virtual.ispe.org/p/s/caution-statistics-ahead-common-mistakes-to-avoid-in-process-validations-statistics-3818
https://virtual.ispe.org/p/s/panel-discussion-3823
https://virtual.ispe.org/p/s/welcome-and-introductions-3828
https://virtual.ispe.org/p/s/pics-general-feedback-on-the-revision-process-of-annex-1-3833
https://virtual.ispe.org/p/s/annex-1-update-ispe-commenting-process-3838
https://virtual.ispe.org/p/s/lab-40-using-operations-and-supply-chain-management-principles-3843
https://virtual.ispe.org/p/s/welcome-and-introductions-3848
https://virtual.ispe.org/p/s/the-future-of-facility-build-outs-innovations-in-qa-and-electronic-validation-3853
https://virtual.ispe.org/p/s/welcome-and-introductions-3858
https://virtual.ispe.org/p/s/welcome-and-introductions-3863
https://virtual.ispe.org/p/s/digital-sops-as-enabler-for-pharma-40-3868
https://virtual.ispe.org/p/s/my-day-in-quality-40-3873
https://virtual.ispe.org/p/s/the-ispe-pharma-40tm-operating-model-and-hcs-what-is-pharma-40-3878
https://virtual.ispe.org/p/s/panel-discussion-3883
https://virtual.ispe.org/p/s/build-a-connected-medical-device-system-3888
https://virtual.ispe.org/p/s/welcome-and-introductions-3893
https://virtual.ispe.org/p/s/the-path-to-patient-scale-cell-therapy-commercialization-3898
https://virtual.ispe.org/p/s/welcome-and-introductions-3903
https://virtual.ispe.org/p/s/pv-lifecycle-stage-1-development-challenges-for-aav-gene-therapy-products-for-rare-diseases-3908
https://virtual.ispe.org/p/s/learnings-from-an-accelerated-development-program-with-a-focus-on-validation-3913
https://virtual.ispe.org/p/s/managing-a-validation-program-under-covid-19-3918
https://virtual.ispe.org/p/s/process-validation-considerations-for-car-t-or-autologous-cell-therapies-3923
https://virtual.ispe.org/p/s/welcome-and-introductions-3928
https://virtual.ispe.org/p/s/welcome-and-introductions-3933
https://virtual.ispe.org/p/s/container-closure-system-suitability-for-cryogenic-storage-packaging-systems-and-storage-of-biologics-and-gene-therapy-3938
https://virtual.ispe.org/p/s/designing-facility-for-biopharmaceutical-hpapis-3943
https://virtual.ispe.org/p/s/welcome-and-introductions-3948
https://virtual.ispe.org/p/s/engineering-and-construction-of-a-bl-2-plant-for-bacterial-phage-3953
https://virtual.ispe.org/p/s/a-framework-for-ensuring-business-performance-for-multi-product-facilities-3958
https://virtual.ispe.org/p/s/welcome-and-introductions-3963
https://virtual.ispe.org/p/s/up-rising-to-the-cloud-challenge-3968
https://virtual.ispe.org/p/s/data-integrity-for-machine-learning-3978
https://virtual.ispe.org/p/s/building-a-workforce-to-fuel-the-future-of-pharma-3983
https://virtual.ispe.org/p/s/a-view-into-pharma-40-technologies-to-support-human-activity-3988
https://virtual.ispe.org/p/s/welcome-and-introductions-3993
https://virtual.ispe.org/p/s/digital-transformation-in-manufacturing-3998
https://virtual.ispe.org/p/s/flexible-high-potency-clinical-manufacturing-4003
https://virtual.ispe.org/p/s/modular-engineering-in-the-life-sciences-industry-4008
https://virtual.ispe.org/p/s/creating-a-new-industry-standard-for-fillfinish-of-small-batches-4013
https://virtual.ispe.org/p/s/welcome-and-introductions-4018
https://virtual.ispe.org/p/s/updates-on-recent-combination-product-initiatives-at-the-us-fda-4023
https://virtual.ispe.org/p/s/panel-discussion-4028
https://virtual.ispe.org/p/s/china-combination-products-4033
https://virtual.ispe.org/p/s/eu-mdr-impact-on-combination-products-4038
https://virtual.ispe.org/p/s/welcome-and-introductions-4043
https://virtual.ispe.org/p/s/advanced-therapeutics-manufacturing-strategy-make-vs-buy-4048
https://virtual.ispe.org/p/s/welcome-and-introductions-4053
https://virtual.ispe.org/p/s/build-or-buy-decentralized-vs-centralized-4058
https://virtual.ispe.org/p/s/panel-discussion-4063
https://virtual.ispe.org/p/s/process-and-technology-4068
https://virtual.ispe.org/p/s/welcome-and-introductions-4073
https://virtual.ispe.org/p/s/facility-planning-and-design-4078
https://virtual.ispe.org/p/s/investing-in-the-future-4083
https://virtual.ispe.org/p/s/project-execution-and-results-4088
https://virtual.ispe.org/p/s/digital-twin-the-last-frontier-of-pharma-production-4093
https://virtual.ispe.org/p/s/welcome-and-introductions-4098
https://virtual.ispe.org/p/s/pharma-40-scenarios-lessons-learned-directions-4103
https://virtual.ispe.org/p/s/zero-trust-architecture-as-part-of-a-pharma-40-strategy-4108
https://virtual.ispe.org/p/s/process-validation-of-suspension-lentiviral-vector-process-4113
https://virtual.ispe.org/p/s/rapid-vaccineviral-vector-deployment-using-flexible-biomanufacturing-platforms-4118
https://virtual.ispe.org/p/s/welcome-and-introductions-4123
https://virtual.ispe.org/p/s/cell-therapies-new-and-old-challenges-4128
https://virtual.ispe.org/p/s/panel-discussion-4133
https://virtual.ispe.org/p/s/advanced-control-strategies-and-applications-for-continuous-drug-product-manufacture-4138
https://virtual.ispe.org/p/s/harness-the-power-of-measurement-data-and-model-a-novel-hybrid-in-process-control-for-continuous-direct-compression-process-line-pcmm-4143
https://virtual.ispe.org/p/s/welcome-and-introductions-4148
https://virtual.ispe.org/p/s/advanced-control-strategies-applied-in-the-world-of-the-large-molecule-catching-up-with-osd-on-the-journey-to-the-performance-based-approach-4153
https://virtual.ispe.org/p/s/the-impact-of-cellgene-therapy-construction-on-the-supply-chain-4158
https://virtual.ispe.org/p/s/welcome-and-introductions-4163
https://virtual.ispe.org/p/s/cellgene-therapy-market-developments-effect-on-manufacturing-supply-chain-4168
https://virtual.ispe.org/p/s/considerations-for-global-cell-supply-chain-consistency-4173
https://virtual.ispe.org/p/s/panel-discussion-4178
https://virtual.ispe.org/p/s/welcome-and-opening-4187
https://virtual.ispe.org/p/s/learning-from-covid-panel-4197
https://virtual.ispe.org/p/s/workforce-of-the-future-4203
https://virtual.ispe.org/p/s/advancing-pharmaceutical-quality-power-of-data-and-analytics-4213
https://virtual.ispe.org/p/s/supply-chain-impact-from-cmo-viewpoint-4222
https://virtual.ispe.org/p/s/closing-and-next-steps-4231
https://virtual.ispe.org/p/s/welcome-to-2020-ispe-pharma-40-virtual-conference-4292
https://virtual.ispe.org/p/s/a-vision-of-pharma-40-operations-4297
https://virtual.ispe.org/p/s/boost-and-sustain-performance-for-tomorrow-4302
https://virtual.ispe.org/p/s/joining-forces-driving-digitalization-for-pharma-manufacturing-4307
https://virtual.ispe.org/p/s/lillys-perspective-on-future-operations-in-the-new-era-of-digitisation-and-ai-4312
https://virtual.ispe.org/p/s/connected-health-world-after-covid-digital-therapeutics-4317
https://virtual.ispe.org/p/s/panel-discussion-with-speakers-from-the-track-pharma-40-vision-4322
https://virtual.ispe.org/p/s/my-life-in-quality-40-lets-imagine-pharma-40-in-real-life-what-would-my-day-to-day-business-look-like-4327
https://virtual.ispe.org/p/s/fair-data-for-better-patient-outcomes-4332
https://virtual.ispe.org/p/s/connected-worker-4337
https://virtual.ispe.org/p/s/scalable-centralised-and-system-wide-audit-trail-review-and-visualisation-4342
https://virtual.ispe.org/p/s/panel-discussion-with-speakers-from-pharma-40-case-studies-track-4347
https://virtual.ispe.org/p/s/workshop-1-process-maps-and-critical-thinking-4352
https://virtual.ispe.org/p/s/workshop-2-plug-and-produce-pharma-40-equipment-connectivity-the-journey-towards-bio-pharma-manufacturing-40-4357
https://virtual.ispe.org/p/s/closing-remarks-by-tom-hartman-ispe-ceo-and-president-4362
https://virtual.ispe.org/p/s/ispe-pharma-40-fourth-survey-where-are-we-now-4367
https://virtual.ispe.org/p/s/authorities-between-keeping-pace-with-innovation-and-maintaining-regulatory-oversight-4372
https://virtual.ispe.org/p/s/assisted-reality-on-the-shop-floor-4377
https://virtual.ispe.org/p/s/smart-solutions-with-wearable-devices-for-maintenance-operators-4382
https://virtual.ispe.org/p/s/panel-discussion-with-speakers-from-pharma-40-and-regulations-track-4387
https://virtual.ispe.org/p/s/workshop-3-holistic-control-strategy-and-how-a-digital-maturity-model-is-utilised-to-enable-pharma-40-4392
https://virtual.ispe.org/p/s/workshop-4-how-to-pitch-shape-estimate-and-kick-off-a-pharma-40-project-4397
https://virtual.ispe.org/p/s/plant-tour-janssen-sciences-ireland-uc-4402
https://virtual.ispe.org/p/s/plant-tour-eli-lilly-4407
https://virtual.ispe.org/p/s/plant-tour-goodly-innovations-4412
https://virtual.ispe.org/p/s/welcome-4422
https://virtual.ispe.org/p/s/question-and-answerdiscussionclosing-4867
https://virtual.ispe.org/p/s/introduction-and-presentation-by-fda-5857
https://virtual.ispe.org/p/s/question-and-answerdiscussionclosing-5929
https://virtual.ispe.org/p/s/artificial-intelligence-for-connected-health-post-covid-technical-and-ethical-challenges-5956
https://virtual.ispe.org/p/cf/2021-ispe-aseptic-conference-6174
https://virtual.ispe.org/p/s/opening-plenary-session-6236
https://virtual.ispe.org/p/s/intersection-of-atmps-and-new-technologies-6241
https://virtual.ispe.org/p/s/facility-considerations-for-next-generation-manufacturing-6246
https://virtual.ispe.org/p/s/containment-understanding-why-when-and-what-regulatory-agencies-expect-6251
https://virtual.ispe.org/p/s/revision-of-eu-gmps-annex-1-what-impacts-can-we-expect-as-an-industry-6256
https://virtual.ispe.org/p/s/h2o2-not-the-same-old-topic-6261
https://virtual.ispe.org/p/s/modular-robotic-fillfinish-lines-6266
https://virtual.ispe.org/p/s/single-use-technologies-are-they-sustainable-6271
https://virtual.ispe.org/p/s/process-safety-6276
https://virtual.ispe.org/p/s/devices-and-decontamination-overcoming-challenges-6281
https://virtual.ispe.org/p/s/regulatory-and-industry-panel-6286
https://virtual.ispe.org/p/s/contamination-and-cross-contamination-control-for-bio-safety-6294
https://virtual.ispe.org/p/s/regulatory-view-on-atmps-and-make-vs-buy-6303
https://virtual.ispe.org/p/s/qrm-based-c-and-q-for-an-animal-health-biopharmaceutical-facility-6566
https://virtual.ispe.org/p/s/adcs-and-state-of-the-art-fill-finish-technology-6658
https://virtual.ispe.org/p/s/us-food-and-drug-administration-us-fda-6755
https://virtual.ispe.org/p/s/european-medicines-agency-ema-6760
https://virtual.ispe.org/p/s/medicines-and-healthcare-regulatory-agency-mhra-6765
https://virtual.ispe.org/p/s/health-products-regulatory-authority-hpra-and-pharmaceutical-inspection-co-operation-scheme-pics-6770
https://virtual.ispe.org/p/s/regulatory-panel-discussion-6780
https://virtual.ispe.org/p/s/welcome-and-opening-remarks-6937
https://virtual.ispe.org/p/s/atmps-cell-and-gene-therapy-challenges-and-opportunities-for-this-emerging-modality-and-panel-discussion-6946
https://virtual.ispe.org/p/s/regulatory-changes-during-a-pandemic-cmc-inspections-and-reviews-panel-discussion-6956
https://virtual.ispe.org/p/s/covid-lessons-on-development-to-distribution-to-post-marketing-6964
https://virtual.ispe.org/p/cf/2021-apac-pharmaceutical-manufacturing-conference-and-global-regulatory-summit-6971
https://virtual.ispe.org/p/s/apac-pharmaceutical-manufacturing-conference-opening-plenary-session-7059
https://virtual.ispe.org/p/s/case-study-1-practical-applications-for-oos-investigationsassessments-7069
https://virtual.ispe.org/p/s/case-study-2-cross-contamination-controls-7079
https://virtual.ispe.org/p/s/case-study-3-critical-review-of-quality-and-manufacturing-data-7084
https://virtual.ispe.org/p/s/case-study-4-aseptic-processing-controls-7094
https://virtual.ispe.org/p/s/case-study-1-practical-applications-for-oos-investigationsassessments-7104
https://virtual.ispe.org/p/s/case-study-2-cross-contamination-controls-7109
https://virtual.ispe.org/p/s/case-study-3-critical-review-of-quality-and-manufacturing-data-7114
https://virtual.ispe.org/p/s/case-study-4-aseptic-processing-controls-7119
https://virtual.ispe.org/p/s/case-study-report-outs-and-discussion-7124
https://virtual.ispe.org/p/s/adapting-during-the-pandemic-changing-regulatory-processes-7129
https://virtual.ispe.org/p/s/creating-comprehensive-responses-to-regulatory-actions-7134
https://virtual.ispe.org/p/s/cmocdmo-relationships-management-and-quality-7139
https://virtual.ispe.org/p/s/regulatory-and-industry-panel-7144
https://virtual.ispe.org/p/s/global-regulatory-pharmaceutical-summit-opening-plenary-session-7153
https://virtual.ispe.org/p/s/us-fda-7173
https://virtual.ispe.org/p/s/global-regulatory-pharmaceutical-summit-regulatory-and-industry-panel-discussion-7183
https://virtual.ispe.org/p/s/title-tbd-7268
https://virtual.ispe.org/p/s/case-study-report-outs-7298
https://virtual.ispe.org/p/s/opening-remarks-and-introductions-7395
https://virtual.ispe.org/p/cf/2021-ispe-biotechnology-conference-and-workshop-7402
https://virtual.ispe.org/p/s/welcome-and-introduction-7434
https://virtual.ispe.org/p/s/ispe-foundation-7439
https://virtual.ispe.org/p/s/development-of-cell-and-gene-therapies-during-covid-19-pandemic-7444
https://virtual.ispe.org/p/s/regulatory-aspects-for-atmps-based-on-pics-annex-2-2a-and-eu-gmp-annex-1-7449
https://virtual.ispe.org/p/s/vaccines-and-monoclonal-antibodies-to-regain-our-freedom-7454
https://virtual.ispe.org/p/s/implementation-of-electronic-batch-records-in-cell-therapy-positives-and-challenges-7459
https://virtual.ispe.org/p/s/networking-break-in-the-ispe-networking-lounge-7464
https://virtual.ispe.org/p/s/cellular-and-gene-therapy-products-a-cmc-regulatory-perspective-7469
https://virtual.ispe.org/p/s/biontechs-road-to-one-billion-doses-of-mrna-vaccines-7474
https://virtual.ispe.org/p/s/manufacturing-an-adenovirus-vectored-covid-19-vaccine-from-bench-to-millions-of-doses-in-months-7479
https://virtual.ispe.org/p/s/panel-discussion-with-the-keynote-speakers-and-closing-remarks-7484
https://virtual.ispe.org/p/s/workshop-1-control-strategy-technology-transfer-cmc-computer-based-modeling-el-article-7489
https://virtual.ispe.org/p/s/validation-40-applied-fda-good-machine-learning-practices-case-studies-7494
https://virtual.ispe.org/p/s/operational-excellence-in-the-pharmaceutical-industry-from-innocence-to-world-leading-7499
https://virtual.ispe.org/p/s/car-t-manufacturing-a-fast-evolution-through-challenges-and-opportunities-7504
https://virtual.ispe.org/p/s/specification-driven-acceptance-criteria-based-on-a-holistic-ipm-7509
https://virtual.ispe.org/p/s/designing-for-operation-readiness-7514
https://virtual.ispe.org/p/s/modular-and-flexible-manufacturing-for-cell-and-gene-therapies-7519
https://virtual.ispe.org/p/s/digitalisation-for-construction-management-of-large-biopharmaceutical-plants-case-study-7524
https://virtual.ispe.org/p/s/retrofitting-an-existing-bioprocessing-facility-for-vector-manufacturing-a-case-study-in-managing-major-manufacturing-process-changes-mid-project-7529
https://virtual.ispe.org/p/s/quality-and-regulatory-challenges-surrounding-cell-and-gene-therapy-products-7534
https://virtual.ispe.org/p/s/digital-transformation-in-biomanufacturing-a-risk-and-compliance-perspective-7539
https://virtual.ispe.org/p/s/operation-readiness-7544
https://virtual.ispe.org/p/s/individualised-neo-antigen-specific-therapies-unique-cmc-challenges-and-a-novel-regulatory-framework-7549
https://virtual.ispe.org/p/s/networking-break-in-the-ispe-networking-lounge-7554
https://virtual.ispe.org/p/s/machine-learning-assisted-downstream-process-development-case-studies-7559
https://virtual.ispe.org/p/s/designing-for-operation-readiness-7564
https://virtual.ispe.org/p/s/establishing-supply-chain-capabilities-for-individualised-therapies-7569
https://virtual.ispe.org/p/s/gene-expression-dynamics-under-simulated-fluctuating-substrate-conditions-derived-from-a-scale-down-reactor-7574
https://virtual.ispe.org/p/s/panel-discussion-with-speakers-in-track-2-operations-readiness-technology-transfer-and-risk-based-case-studies-and-closing-remarks-7579
https://virtual.ispe.org/p/s/panel-discussion-with-speakers-in-track-3-cell-and-gene-therapy-products-atmps-projects-commercial-manufacturing-and-closing-remarks-7584
https://virtual.ispe.org/p/s/panel-discussion-with-speakers-in-track-1-pharma-40-in-biotechnology-accelerated-by-digitalisation-and-closing-remarks-7589
https://virtual.ispe.org/p/s/networking-break-in-the-ispe-networking-lounge-7594
https://virtual.ispe.org/p/s/workshop-2-work-stream-atmps-facility-design-gxp-compliance-7599
https://virtual.ispe.org/p/s/terminal-sterilisation-of-oligonucleotides-insights-and-recommendations-7604
https://virtual.ispe.org/p/s/advancing-pat-and-automation-for-advanced-therapeutic-modalities-7609
https://virtual.ispe.org/p/s/project-lightspeed-development-and-manufacturing-of-comirnaty-r-an-mrna-based-vaccine-against-covid-19-7614
https://virtual.ispe.org/p/s/current-regulatory-trends-for-synthetic-oligonucleotides-7619
https://virtual.ispe.org/p/s/downstream-continuous-biomanufacturing-membrane-chromatography-in-mabs-manufacturing-7624
https://virtual.ispe.org/p/s/making-the-impossible-possible-7629
https://virtual.ispe.org/p/s/potential-uses-of-exosomes-in-therapy-and-diagnostics-7634
https://virtual.ispe.org/p/s/large-molecule-drug-substance-process-intensification-at-janssen-pharmaceuticals-7639
https://virtual.ispe.org/p/s/immediate-supply-to-covid-19-vaccines-manufacturers-7644
https://virtual.ispe.org/p/s/electrospun-scaffolds-for-dermal-tissue-engineering-7649
https://virtual.ispe.org/p/s/concept-of-real-time-quality-and-release-advanced-analytics-for-cm-7654
https://virtual.ispe.org/p/s/networking-break-in-the-ispe-networking-lounge-7659
https://virtual.ispe.org/p/s/cell-therapies-going-off-the-shelf-the-beauty-of-cord-blood-stem-cell-derived-natural-killer-cells-7664
https://virtual.ispe.org/p/s/from-vision-to-implementation-strategies-and-innovations-that-enable-the-transition-to-a-compact-and-continuous-manufacturing-process-for-therapeutic-proteins-7669
https://virtual.ispe.org/p/s/supply-chain-for-covid-19-vaccines-7674
https://virtual.ispe.org/p/s/comparison-of-host-cell-dna-levels-in-aav28-fix-from-hek293-adherent-and-suspension-cell-culture-7679
https://virtual.ispe.org/p/s/harmonizing-rapid-contamination-detection-across-the-biomanufacturing-process-through-atp-bioluminescence-7684
https://virtual.ispe.org/p/s/accelarating-the-moderna-covid-19-vaccine-to-commercial-supply-7689
https://virtual.ispe.org/p/s/update-pics-annex-2a-for-atmps-revision-and-pics-on-cell-and-tissues-7694
https://virtual.ispe.org/p/s/astm-international-consensus-standards-facilitating-productivity-in-bioprocessing-7699
https://virtual.ispe.org/p/s/panel-discussion-with-speakers-in-track-5-covid-19-vaccines-development-manufacturing-distribution-vaccination-impact-current-situation-and-closing-remarks-7704
https://virtual.ispe.org/p/s/panel-discussion-with-speakers-in-track-4-cell-and-gene-therapy-atmps-data-science-research-and-development-and-closing-remarks-7709
https://virtual.ispe.org/p/s/welcome-and-introduction-and-keynotes-7713
https://virtual.ispe.org/p/s/track-1-pharma-40-in-biotechnology-accelerated-by-digitalisation-7714
https://virtual.ispe.org/p/s/track-2-operations-readiness-technology-transfer-and-risk-based-case-studies-7717
https://virtual.ispe.org/p/s/track-3-cell-and-gene-therapy-products-atmps-projects-commercial-manufacturing-7719
https://virtual.ispe.org/p/s/track-4-cell-and-gene-therapy-atmps-data-science-research-and-development-7724
https://virtual.ispe.org/p/s/track-5-covid-19-vaccines-development-manufacturing-distribution-vaccination-impact-current-situation-7729
https://virtual.ispe.org/p/s/track-6-mabs-continuous-biomanufacturing-technology-enablers-and-rationalisation-7730
https://virtual.ispe.org/p/s/panel-discussion-with-speakers-in-track-6-mabs-continuous-biomanufacturing-technology-enablers-and-rationalisation-and-closing-remarks-7732
https://virtual.ispe.org/p/s/panel-discussion-with-regulators-and-closing-remarks-7735
https://virtual.ispe.org/p/s/plant-tour-eli-lilly-drug-substance-campus-cork-ireland-biologics-and-small-molecule-drug-substance-manufacturing-7739
https://virtual.ispe.org/p/s/plant-tour-janssen-biologics-site-ringaskiddy-cork-ireland-antibody-drug-substance-manufacturing-7740
https://virtual.ispe.org/p/s/plant-tour-takeda-cell-therapy-7743
https://virtual.ispe.org/p/s/plant-tour-wuxi-biologics-7747
https://virtual.ispe.org/p/s/foya-category-winner-presentations-7859
https://virtual.ispe.org/p/s/opening-plenary-session-7889
https://virtual.ispe.org/p/s/concurrent-session-new-approaches-to-process-agility-and-reliability-7909
https://virtual.ispe.org/p/s/concurrent-session-qrmcqv-best-practices-and-lessons-learned-7914
https://virtual.ispe.org/p/s/concurrent-session-digital-innovation-ensuring-quality-and-regulatory-compliant-solutions-7919
https://virtual.ispe.org/p/s/concurrent-session-fill-finish-7924
https://virtual.ispe.org/p/s/concurrent-session-path-to-a-global-quality-dossier-part-1-7929
https://virtual.ispe.org/p/s/concurrent-session-drug-shortages-and-meeting-supply-chain-challenges-7934
https://virtual.ispe.org/p/s/concurrent-session-increasing-facility-flexibility-through-improving-turnarounds-and-new-product-introduction-7954
https://virtual.ispe.org/p/s/concurrent-session-car-t-and-the-future-7959
https://virtual.ispe.org/p/s/concurrent-session-gamp-r-5-critical-thinking-agile-methods-and-it-infrastructure-control-7964
https://virtual.ispe.org/p/s/concurrent-session-tech-transfer-7969
https://virtual.ispe.org/p/s/concurrent-session-path-to-a-global-quality-dossier-part-2-7974
https://virtual.ispe.org/p/s/annex-1-manufacture-of-sterile-products-7977
https://virtual.ispe.org/p/s/ilab-intelligent-lean-lab-7982
https://virtual.ispe.org/p/s/the-future-of-facility-build-outs-innovations-in-qa-and-electronic-validation-7987
https://virtual.ispe.org/p/s/quality-40-7992
https://virtual.ispe.org/p/s/connected-medical-device-systems-strategies-and-lessons-learned-7997
https://virtual.ispe.org/p/s/roads-for-car-t-strategies-for-cell-based-atmps-8002
https://virtual.ispe.org/p/s/process-validation-in-biotech-industry-perspectives-and-experiences-8007
https://virtual.ispe.org/p/s/container-closure-for-gene-therapy-products-8012
https://virtual.ispe.org/p/s/designing-for-the-future-using-technology-for-broad-spectrum-compliance-and-functionality-8017
https://virtual.ispe.org/p/s/truth-and-lies-innovative-technologies-and-pharma-40-8022
https://virtual.ispe.org/p/s/digital-transformation-and-smart-manufacturing-future-is-now-8027
https://virtual.ispe.org/p/s/flexible-and-modular-manufacturing-8032
https://virtual.ispe.org/p/s/combination-products-part-2-evolving-global-regulations-health-authority-perspective-8037
https://virtual.ispe.org/p/s/make-vs-buy-business-analysis-in-advanced-therapies-8042
https://virtual.ispe.org/p/s/a-historic-legacy-facility-strengthening-its-future-of-aseptic-processing-8047
https://virtual.ispe.org/p/s/digital-transformation-to-pharma-40-8052
https://virtual.ispe.org/p/s/development-and-manufacturing-challenges-with-atmps-8057
https://virtual.ispe.org/p/s/concurrent-session-innovations-in-supply-chain-and-cgt-operations-8067
https://virtual.ispe.org/p/s/membership-and-awards-breakfast-8097
https://virtual.ispe.org/p/s/concurrent-session-learnings-from-covid-innovations-for-parenteral-productivitycapacity-8102
https://virtual.ispe.org/p/s/concurrent-session-pharma-and-the-environment-how-will-we-meet-the-needs-8107
https://virtual.ispe.org/p/s/concurrent-session-lifecycle-management-and-modernization-8112
https://virtual.ispe.org/p/s/concurrent-session-modern-modelling-using-ai-and-algorithm-based-doe-benefits-challenges-and-validation-8117
https://virtual.ispe.org/p/s/concurrent-session-advancing-pharmaceutical-quality-quality-management-maturity-8122
https://virtual.ispe.org/p/s/concurrent-session-scope-response-to-pandemic-challenges-8127
https://virtual.ispe.org/p/s/concurrent-session-atmp-new-modality-processing-approaches-8147
https://virtual.ispe.org/p/s/concurrent-session-project-management-in-a-warp-speed-environment-8152
https://virtual.ispe.org/p/s/concurrent-session-elements-of-digitalization-in-the-pharma-40-journey-8157
https://virtual.ispe.org/p/s/concurrent-session-aseptic-facilities-and-technologies-8162
https://virtual.ispe.org/p/s/concurrent-session-lessons-learned-on-virtual-inspections-and-what-to-take-forward-post-pandemic-8167
https://virtual.ispe.org/p/s/concurrent-session-packaging-and-supply-chain-improvement-8172
https://virtual.ispe.org/p/s/concurrent-session-continuous-drug-substance-manufacturing-coming-of-age-8182
https://virtual.ispe.org/p/s/concurrent-session-steps-to-success-in-a-pharma-facility-8187
https://virtual.ispe.org/p/s/concurrent-session-trends-and-use-cases-for-blockchain-in-biopharma-supply-chain-8192
https://virtual.ispe.org/p/s/concurrent-session-data-analytics-and-ai-8197
https://virtual.ispe.org/p/s/concurrent-session-whats-new-from-ich-8202
https://virtual.ispe.org/p/s/concurrent-session-improving-operations-through-efficiency-8207
https://virtual.ispe.org/p/s/opening-plenary-session-8240
https://virtual.ispe.org/p/s/global-regulatory-town-hall-global-regulatory-insights-on-current-issues-harmonization-and-convergence-8242
https://virtual.ispe.org/p/cf/2022-ispe-facilities-of-the-future-conference-8764
https://virtual.ispe.org/p/s/pharma-40-8830
https://virtual.ispe.org/p/s/bio-manufacturing-of-the-future-8835
https://virtual.ispe.org/p/s/cell-and-gene-therapy-8840
https://virtual.ispe.org/p/s/emerging-technologies-i-8845
https://virtual.ispe.org/p/s/pharma-collaborations-in-the-covid-era-8850
https://virtual.ispe.org/p/s/executive-forum-panel-8855
https://virtual.ispe.org/p/s/benefiting-from-emerging-technologies-8865
https://virtual.ispe.org/p/s/modular-facility-8870
https://virtual.ispe.org/p/s/emerging-technologies-ii-8875
https://virtual.ispe.org/p/s/reducing-the-cost-of-vaccine-delivery-8880
https://virtual.ispe.org/p/s/solving-world-problems-through-modernization-and-lifesaving-drugs-8885
https://virtual.ispe.org/p/s/opening-plenary-covids-impact-on-pharma-facilities-of-the-future-8889
https://virtual.ispe.org/p/s/women-in-pharma-breakfast-session-utilizing-innovative-technology-for-growth-9069
https://virtual.ispe.org/p/cf/2022-ispe-aseptic-conference-9157
https://virtual.ispe.org/p/s/harmonization-efforts-of-pics-and-the-impact-on-aseptic-processing-9201
https://virtual.ispe.org/p/s/a-step-to-human-less-aseptic-operation-continuous-environmental-monitoring-strategy-9206
https://virtual.ispe.org/p/s/contamination-control-risk-and-the-quality-management-system-9211
https://virtual.ispe.org/p/s/retrofit-of-innovative-robotic-solutions-into-existing-production-lines-9216
https://virtual.ispe.org/p/s/industry-panel-overcoming-the-biggest-challenges-in-c-plus-gatmps-9221
https://virtual.ispe.org/p/s/panel-presentations-industry-panel-overcoming-the-biggest-challenges-in-c-plus-gatmps-9226
https://virtual.ispe.org/p/s/breakfast-trends-in-aseptic-processing-applications-impacts-of-covid-atmp-supply-chain-and-more-9231
https://virtual.ispe.org/p/s/projects-during-the-pandemic-technical-and-process-case-studies-9236
https://virtual.ispe.org/p/s/aseptic-group-discussions-annex-1-implementation-challenges-and-opportunities-9241
https://virtual.ispe.org/p/s/barrier-group-discussions-optimizing-your-bio-decontamination-cycle-utilizes-enzyme-indicators-9246
https://virtual.ispe.org/p/s/opening-plenary-session-9251
https://virtual.ispe.org/p/s/concurrent-session-robotics-and-implementation-of-new-strategies-1-9291
https://virtual.ispe.org/p/s/concurrent-session-design-and-development-of-components-in-aseptic-manufacturing-9316
https://virtual.ispe.org/p/s/concurrent-session-robotics-and-implementation-of-new-strategies-2-9346
https://virtual.ispe.org/p/s/concurrent-session-implementing-and-ensuring-robust-contamination-control-9371
https://virtual.ispe.org/p/s/industry-panel-overcoming-the-biggest-challenges-in-c-plus-gatmps-9401
https://virtual.ispe.org/p/s/women-in-pharma-breakfast-session-trends-in-aseptic-processing-applications-impacts-of-covid-atmp-supply-chain-and-more-9441
https://virtual.ispe.org/p/s/plenary-session-microbiological-quality-and-cultivating-emerging-leaders-9466
https://virtual.ispe.org/p/s/concurrent-session-projects-during-the-pandemic-technical-and-process-case-studies-9486
https://virtual.ispe.org/p/s/concurrent-session-enzyme-h2o2-indicators-in-aseptic-production-environment-9536
https://virtual.ispe.org/p/s/interactive-regulatory-panel-9591
https://virtual.ispe.org/p/cf/2022-ispe-europe-annual-conference-9642
https://virtual.ispe.org/p/s/how-to-bring-pharma-40-to-life-and-sustain-it-9654
https://virtual.ispe.org/p/s/tech-trends-that-matter-9659
https://virtual.ispe.org/p/s/the-journey-from-a-solid-to-a-biotech-production-site-9664
https://virtual.ispe.org/p/s/quantum-computing-in-pharma-9674
https://virtual.ispe.org/p/s/otics-cyber-security-for-pharma-40-compliance-and-sustainability-9679
https://virtual.ispe.org/p/s/digital-therapeutics-overcoming-the-barriers-to-adoption-in-healthcare-and-medicine-9684
https://virtual.ispe.org/p/s/looking-into-the-future-facilitating-the-use-of-innovative-manufacturing-approaches-from-an-eu-perspective-9699
https://virtual.ispe.org/p/s/advancing-quality-surveillance-9704
https://virtual.ispe.org/p/s/how-to-make-the-biorevolution-a-reality-building-bayers-cell-and-gene-therapy-platform-9709
https://virtual.ispe.org/p/s/gene-therapy-achievements-and-challenges-9714
https://virtual.ispe.org/p/s/new-eu-pharma-legislation-and-impact-on-pharmaceutical-industry-9724
https://virtual.ispe.org/p/s/2022-facility-of-the-year-award-foya-category-winner-announcements-and-program-overview-9729
https://virtual.ispe.org/p/s/regulatory-panel-a-panel-discussion-with-regulators-on-sustainability-annex-1-implementation-good-engineering-practice-9739
https://virtual.ispe.org/p/s/how-industry-regulatory-affairs-support-sustainability-9749
https://virtual.ispe.org/p/s/ai-supports-intervention-detection-and-classification-in-aseptic-core-9754
https://virtual.ispe.org/p/s/can-ai-boost-the-patient-centric-approach-9759
https://virtual.ispe.org/p/s/foya-facility-integration-ninlaro-facility-takeda-grange-castle-9764
https://virtual.ispe.org/p/s/the-who-pre-qualification-program-and-local-pharma-production-sustainability-9769
https://virtual.ispe.org/p/s/preventing-contamination-and-cross-contamination-with-a-new-cleaning-approach-9774
https://virtual.ispe.org/p/s/pharma-40-holistic-control-strategy-the-vehicle-for-speedy-reliable-consistent-and-predictable-product-supply-9779
https://virtual.ispe.org/p/s/foya-winner-company-9784
https://virtual.ispe.org/p/s/environmental-impacts-of-pharmaceuticals-sudden-tackling-hazards-from-a-life-cycle-perspective-9789
https://virtual.ispe.org/p/s/how-to-accommodate-multiple-modalities-in-the-same-facility-including-cell-and-gene-therapies-9794
https://virtual.ispe.org/p/s/data-driven-qms-document-free-9799
https://virtual.ispe.org/p/s/a-playbook-to-fully-utilise-closed-systems-in-modern-biopharma-facilities-9804
https://virtual.ispe.org/p/s/sustainability-by-design-9824
https://virtual.ispe.org/p/s/how-to-implement-annex-1-in-the-drug-substance-world-a-consensus-9829
https://virtual.ispe.org/p/s/the-role-of-computerized-eclinical-systems-and-data-within-the-sponsor-supplier-investigator-triangle-9834
https://virtual.ispe.org/p/s/foya-janssen-biocork2-project-delivering-products-to-patients-through-innovation-9839
https://virtual.ispe.org/p/s/the-opportunities-and-challenges-with-integrating-a-circular-economy-into-the-development-of-drug-substance-9844
https://virtual.ispe.org/p/s/innovations-in-atmps-and-the-regulatory-framework-9849
https://virtual.ispe.org/p/s/ai-maturity-model-for-gxp-application-setting-the-foundation-for-the-validation-of-ai-9854
https://virtual.ispe.org/p/s/tiger-designing-a-new-project-and-portfolio-management-tool-to-boost-drug-discovery-9859
https://virtual.ispe.org/p/s/the-rise-of-the-symbiosis-how-pharma-can-go-circular-9864
https://virtual.ispe.org/p/s/contamination-control-strategy-for-start-up-cell-therapy-9869
https://virtual.ispe.org/p/s/immersive-digital-technologies-for-pharmaceutical-manufacturing-augmented-execution-systems-aes-9874
https://virtual.ispe.org/p/s/setting-best-practices-through-building-information-modeling-bim-9879
https://virtual.ispe.org/p/s/regulatory-panel-b-panel-discussion-with-regulators-on-digital-transformation-9894
https://virtual.ispe.org/p/s/cimzia-the-pioneering-approach-to-sustainable-packaging-9904
https://virtual.ispe.org/p/s/biofluorescent-particle-counters-an-environmental-monitoring-solution-for-annex-1-and-pharma-40-9909
https://virtual.ispe.org/p/s/virtual-iot-manufacturing-system-use-cases-for-predictive-calibration-of-clean-room-sensors-and-optimized-production-planning-of-an-aseptic-filling-line-9914
https://virtual.ispe.org/p/s/case-study-design-of-hpapi-biomanufacturing-facility-9919
https://virtual.ispe.org/p/s/supply-chain-sustainability-spezzatino-sustainability-and-continuous-manufacturing-9924
https://virtual.ispe.org/p/s/panel-discussion-on-on-annex-1-and-atmp-manufacturing-comparison-9929
https://virtual.ispe.org/p/s/it-infrastructure-qualification-leveraging-automation-9934
https://virtual.ispe.org/p/s/mrna-technology-beyond-covid-19-vaccine-9939
https://virtual.ispe.org/p/s/the-environmental-impacts-of-alternative-mask-use-options-for-healthcare-settings-9949
https://virtual.ispe.org/p/s/genencure-a-fictional-company-created-for-a-6-months-student-project-from-development-to-production-of-a-nebulized-treatment-against-cystic-fibrosis-using-mrna-technology-9954
https://virtual.ispe.org/p/s/validation-in-the-pharma-40-world-9959
https://virtual.ispe.org/p/s/covid-19-vaccine-manufacturers-in-spain-9964
https://virtual.ispe.org/p/s/combining-sustainability-and-annex-1-9974
https://virtual.ispe.org/p/s/critical-thinking-enabling-smarter-compliance-through-csa-and-other-innovative-approaches-9979
https://virtual.ispe.org/p/s/emerging-leaders-hackathon-winner-10006
https://virtual.ispe.org/p/s/risk-based-trace-matrix-for-agile-c-and-q-management-10014
https://virtual.ispe.org/p/s/opening-and-welcome-10019
https://virtual.ispe.org/p/s/operations-readiness-tech-transfer-and-risk-based-case-studies-10030
https://virtual.ispe.org/p/s/atmpsc-and-gt-projects-and-commercial-manufacturing-10031
https://virtual.ispe.org/p/s/enabling-digital-transformations-in-biotech-10032
https://virtual.ispe.org/p/s/atmpsc-and-gt-data-science-and-r-and-d-10033
https://virtual.ispe.org/p/s/convergence-of-digital-transformation-and-process-intensification-panel-discussion-and-q-and-a-10034
https://virtual.ispe.org/p/s/executive-panel-risk-management-for-future-disruptions-10035
https://virtual.ispe.org/p/s/expanding-your-footprint-opportunities-in-biotech-presented-by-women-in-pharma-r-10036
https://virtual.ispe.org/p/s/welcome-and-opening-remarks-10040
https://virtual.ispe.org/p/s/opening-keynote-10041
https://virtual.ispe.org/p/s/applications-of-mrna-technologies-10043
https://virtual.ispe.org/p/s/process-intensification-10053
https://virtual.ispe.org/p/s/sustainability-in-the-biopharmaceutical-industry-10058
https://virtual.ispe.org/p/s/closing-keynote-10060
https://virtual.ispe.org/p/s/closing-remarks-and-adjourn-10061
https://virtual.ispe.org/p/s/atmpsc-and-gt-projects-and-science-panel-discussion-and-q-and-a-10067
https://virtual.ispe.org/p/s/concurrent-session-ich-q12-implementation-progress-and-future-opportunities-10130
https://virtual.ispe.org/p/s/facility-of-the-year-foya-dinner-and-awards-10143
https://virtual.ispe.org/p/s/opening-keynote-session-10146
https://virtual.ispe.org/p/s/pharma-40-industry-status-and-methodologies-10163
https://virtual.ispe.org/p/s/transportable-small-footprint-biopharmaceutical-manufacturing-facilities-a-regulatory-perspective-10167
https://virtual.ispe.org/p/s/building-a-quality-organization-10171
https://virtual.ispe.org/p/s/gpg-good-engineering-practices-at-operation-warp-speed-10175
https://virtual.ispe.org/p/s/patient-centric-development-strategies-10178
https://virtual.ispe.org/p/s/new-gamp-5-second-edition-an-overview-10193
https://virtual.ispe.org/p/s/increasing-assurance-in-h2o2-cycle-efficacy-with-enzyme-indicators-eis-10197
https://virtual.ispe.org/p/s/quality-and-regulatory-challenges-in-atmps-10201
https://virtual.ispe.org/p/s/drug-shortages-progress-in-a-challenging-year-10207
https://virtual.ispe.org/p/s/combination-products-evolving-state-of-the-art-10211
https://virtual.ispe.org/p/s/new-gamp-5-second-edition-roundtable-10216
https://virtual.ispe.org/p/s/investing-in-legacy-facilities-how-to-get-the-most-bang-for-your-buck-10222
https://virtual.ispe.org/p/s/robust-apq-and-fda-quality-management-maturity-10224
https://virtual.ispe.org/p/s/challenges-and-opportunities-in-plant-to-patient-supply-10227
https://virtual.ispe.org/p/s/3-in-1-assets-sustainability-and-social-impact-10231
https://virtual.ispe.org/p/s/keynote-session-10237
https://virtual.ispe.org/p/s/new-paradigm-for-analytical-methods-ich-q2r2-and-q14-10252
https://virtual.ispe.org/p/s/moving-from-pharma-30-to-40-and-harnessing-the-power-of-the-pharma-40-vision-10256
https://virtual.ispe.org/p/s/meeting-increasing-sustainability-expectations-within-the-pharmaceutical-manufacturing-environment-10260
https://virtual.ispe.org/p/s/navigating-the-supply-chain-for-atmps-10264
https://virtual.ispe.org/p/s/coping-with-data-integrity-and-digitalization-in-supply-chain-10268
https://virtual.ispe.org/p/s/membership-meeting-and-awards-lunch-10272
https://virtual.ispe.org/p/s/ruling-the-digital-transformation-effective-data-management-and-analytics-in-the-manufacturing-processes-10283
https://virtual.ispe.org/p/s/forecasting-the-future-applying-innovative-technology-for-improved-work-applications-10287
https://virtual.ispe.org/p/s/ich-q12-implementation-progress-and-future-opportunities-10291
https://virtual.ispe.org/p/s/blockchain-industry-trends-and-use-cases-10295
https://virtual.ispe.org/p/s/continuous-manufacturing-in-the-osd-industry-a-business-model-comparison-case-study-and-lessons-learned-10299
https://virtual.ispe.org/p/s/keeping-up-in-the-digital-world-a-dive-into-validation-10314
https://virtual.ispe.org/p/s/product-lifecycle-lifecycle-maturity-model-and-real-time-release-testing-for-biotech-products-10318
https://virtual.ispe.org/p/s/regulatory-considerations-to-boost-innovation-and-supply-chain-resilience-10322
https://virtual.ispe.org/p/s/managing-atmp-data-interactions-with-blockchain-panel-discussion-10326
https://virtual.ispe.org/p/s/innovations-and-emerging-technologies-in-projects-ramp-up-and-production-10330
https://virtual.ispe.org/p/s/regulatory-keynote-10336
https://virtual.ispe.org/p/s/global-regulatory-town-hall-10338
https://virtual.ispe.org/p/s/closing-keynote-session-10346
https://virtual.ispe.org/p/s/workshop-process-validation-emerging-challenges-and-hot-topics-10349
https://virtual.ispe.org/p/s/workshop-career-connections-developing-your-personal-brand-10350
https://virtual.ispe.org/p/s/concurrent-session-quality-and-regulatory-challenges-in-atmps-10351
https://virtual.ispe.org/p/s/concurrent-session-drug-shortages-progress-in-a-challenging-year-10352
https://virtual.ispe.org/p/s/concurrent-session-ruling-the-digital-transformation-effective-data-management-and-analytics-in-the-manufacturing-processes-10353
https://virtual.ispe.org/p/s/sponsored-session-sustainability-lessons-10360
https://virtual.ispe.org/p/s/sponsored-session-corporate-lessons-in-sustainability-and-benchmarking-10363
https://virtual.ispe.org/p/cf/2022-ispe-pharma-40-and-annex-1-conference-10372
https://virtual.ispe.org/p/s/professional-development-presented-by-ispe-women-in-pharma-10384
https://virtual.ispe.org/p/s/welcome-message-from-president-and-ceo-of-ispe-10385
https://virtual.ispe.org/p/s/concurrent-session-pharma-40-industry-status-and-methodologies-10386
https://virtual.ispe.org/p/s/concurrent-session-transportable-small-footprint-biopharmaceutical-manufacturing-facilities-a-regulatory-perspective-10387
https://virtual.ispe.org/p/s/concurrent-session-building-a-quality-organization-10388
https://virtual.ispe.org/p/s/concurrent-session-gpg-good-engineering-practices-at-operation-warp-speed-10389
https://virtual.ispe.org/p/s/concurrent-session-patient-centric-development-strategies-10390
https://virtual.ispe.org/p/s/concurrent-session-new-gamp-5-second-edition-an-overview-10391
https://virtual.ispe.org/p/s/concurrent-session-increasing-assurance-in-h2o2-cycle-efficacy-with-enzyme-indicators-eis-10392
https://virtual.ispe.org/p/s/concurrent-session-combination-products-evolving-state-of-the-art-10393
https://virtual.ispe.org/p/s/concurrent-session-new-gamp-5-second-edition-roundtable-10394
https://virtual.ispe.org/p/s/concurrent-session-investing-in-legacy-facilities-how-to-get-the-most-bang-for-your-buck-10395
https://virtual.ispe.org/p/s/concurrent-session-robust-apq-and-fda-quality-management-maturity-10396
https://virtual.ispe.org/p/s/concurrent-session-challenges-and-opportunities-in-plant-to-patient-supply-10397
https://virtual.ispe.org/p/s/concurrent-session-3-in-1-assets-sustainability-and-social-impact-10398
https://virtual.ispe.org/p/s/concurrent-session-moving-from-pharma-30-to-40-and-harnessing-the-power-of-the-pharma-40-vision-10399
https://virtual.ispe.org/p/s/concurrent-session-meeting-increasing-sustainability-expectations-within-the-pharmaceutical-manufacturing-environment-10400
https://virtual.ispe.org/p/s/concurrent-session-new-paradigm-for-analytical-methods-ich-q2r2-and-q14-10401
https://virtual.ispe.org/p/s/concurrent-session-navigating-the-supply-chain-for-atmps-10402
https://virtual.ispe.org/p/s/concurrent-session-coping-with-data-integrity-and-digitalization-in-supply-chain-10403
https://virtual.ispe.org/p/s/ispe-membership-meeting-and-awards-lunch-open-to-all-attendees-10404
https://virtual.ispe.org/p/s/concurrent-session-forecasting-the-future-applying-innovative-technology-for-improved-work-applications-10405
https://virtual.ispe.org/p/s/concurrent-session-blockchain-industry-trends-and-use-cases-10406
https://virtual.ispe.org/p/s/concurrent-session-continuous-manufacturing-in-the-osd-industry-a-business-model-comparison-case-study-and-lessons-learned-10407
https://virtual.ispe.org/p/s/sponsored-session-the-key-benefits-of-a-digitized-cleaning-validation-program-10408
https://virtual.ispe.org/p/s/concurrent-session-keeping-up-in-the-digital-world-a-dive-into-validation-10409
https://virtual.ispe.org/p/s/concurrent-session-product-lifecycle-lifecycle-maturity-model-and-real-time-release-testing-for-biotech-products-10410
https://virtual.ispe.org/p/s/concurrent-session-regulatory-considerations-to-boost-innovation-and-supply-chain-resilience-10411
https://virtual.ispe.org/p/s/concurrent-session-managing-atmp-data-interactions-with-blockchain-panel-discussion-10412
https://virtual.ispe.org/p/s/concurrent-session-innovations-and-emerging-technologies-in-projects-ramp-up-and-production-10413
https://virtual.ispe.org/p/s/training-course-gamp-r-5-annex-11part-11-basic-principles-cont-10414
https://virtual.ispe.org/p/s/introduction-from-conference-chairs-10415
https://virtual.ispe.org/p/s/where-are-we-with-pharma-40-10416
https://virtual.ispe.org/p/s/digitalisation-and-surveillance-expectations-10417
https://virtual.ispe.org/p/s/manufacturing-40-modernisation-of-facilities-and-processes-to-optimise-quality-and-supply-10418
https://virtual.ispe.org/p/s/networking-break-in-the-exhibition-area-foyer-10419
https://virtual.ispe.org/p/s/the-tangible-execution-of-our-smart-manufacturing-vision-10420
https://virtual.ispe.org/p/s/is-pharma-40-the-answer-to-bridging-operational-excellence-and-esg-ambitions-10421
https://virtual.ispe.org/p/s/update-to-the-annex-1-guideline-on-manufacture-of-sterile-products-10422
https://virtual.ispe.org/p/s/lunch-and-networking-break-in-the-exhibition-area-foyer-10423
https://virtual.ispe.org/p/s/integrated-process-modelling-for-quality-40-a-holistic-control-strategy-from-process-to-patient-10424
https://virtual.ispe.org/p/s/discussion-on-the-new-annex-1-implementation-10425
https://virtual.ispe.org/p/s/the-application-of-rtrt-principles-to-large-molecules-10426
https://virtual.ispe.org/p/s/networking-break-in-the-exhibition-area-foyer-10427
https://virtual.ispe.org/p/s/pharma-40-challenges-and-successes-presented-by-ispe-women-in-pharma-10428
https://virtual.ispe.org/p/s/discussion-on-the-new-eu-gmp-annex-1-and-computerised-system-10429
https://virtual.ispe.org/p/s/analytical-design-spaces-interconnected-first-principle-modeling-for-faster-time-to-market-10430
https://virtual.ispe.org/p/s/psms-journey-to-pharma-40-best-practices-of-digitalisation-and-pharma-40-in-the-cdmo-landscape-10431
https://virtual.ispe.org/p/s/hackathon-on-umbrella-quality-40-10432
https://virtual.ispe.org/p/s/contamination-control-transfer-systems-like-e-beam-10433
https://virtual.ispe.org/p/s/using-deep-learning-for-visual-inspection-10434
https://virtual.ispe.org/p/s/networking-reception-in-the-exhibition-area-foyer-10435
https://virtual.ispe.org/p/s/conference-networking-dinner-palais-coburg-10436
https://virtual.ispe.org/p/s/work-life-balance-presented-by-women-in-pharma-10437
https://virtual.ispe.org/p/s/annex-1-eudralex-volume-4-where-are-we-regarding-the-time-to-implementing-the-new-requirements-10438
https://virtual.ispe.org/p/s/setting-the-stage-for-edata-exchange-10439
https://virtual.ispe.org/p/s/single-use-systems-characterisation-how-standardised-extractables-data-support-e-and-l-risk-assessment-10440
https://virtual.ispe.org/p/s/revolutionizing-visual-inspection-through-artificial-intelligence-10441
https://virtual.ispe.org/p/s/new-annex-1-challenges-for-lvp-bag-manufacturing-10442
https://virtual.ispe.org/p/s/standardized-integration-for-lab-robots-10443
https://virtual.ispe.org/p/s/networking-break-in-the-exhibition-area-foyer-10444
https://virtual.ispe.org/p/s/pharma-40tm-6th-survey-latest-results-and-trends-10445
https://virtual.ispe.org/p/s/regulatory-panel-annex-1-implementation-10446
https://virtual.ispe.org/p/s/lunch-and-networking-break-in-the-exhibition-area-foyer-10447
https://virtual.ispe.org/p/s/reflection-presented-by-ispe-women-in-pharma-10448
https://virtual.ispe.org/p/s/regulatory-view-on-the-holistic-control-strategy-and-digital-maturity-10449
https://virtual.ispe.org/p/s/mivarep-an-innovative-percutaneous-valve-a-production-challenge-for-pharmacy-students-10450
https://virtual.ispe.org/p/s/the-road-to-operational-readiness-through-the-lens-of-digitization-and-process-knowledge-management-10451
https://virtual.ispe.org/p/s/real-time-environmental-monitoring-10452
https://virtual.ispe.org/p/s/chartering-a-holistic-path-to-deliver-transformational-value-at-scale-for-pharma-40-10453
https://virtual.ispe.org/p/s/a-step-towards-human-less-continuous-environmental-monitoring-10454
https://virtual.ispe.org/p/s/networking-break-in-the-exhibition-area-foyer-10455
https://virtual.ispe.org/p/s/digitalising-an-aseptic-manufacturer-a-holistic-perspective-to-build-a-sound-roadmap-10456
https://virtual.ispe.org/p/s/panel-discussion-on-continuous-environmental-monitoring-10457
https://virtual.ispe.org/p/s/implementing-pharma-40-10458
https://virtual.ispe.org/p/s/engineering-changes-and-solutions-approaching-the-new-annex-1-2022-in-existing-facilities-10459
https://virtual.ispe.org/p/s/plant-tour-takeda-10460
https://virtual.ispe.org/p/s/plant-tour-living-lab-siemens-10461
https://virtual.ispe.org/p/cf/2023-ispe-facilities-of-the-future-conference-10463
https://virtual.ispe.org/p/s/lessons-learned-chartering-a-40-digital-transformation-10472
https://virtual.ispe.org/p/s/sustainable-manufacturing-trends-in-medical-cannabis-10474
https://virtual.ispe.org/p/s/right-first-time-manufacturing-going-slower-to-move-faster-10475
https://virtual.ispe.org/p/s/the-critical-convergence-of-work-force-planning-leadership-and-digital-transformation-10477
https://virtual.ispe.org/p/s/regulatory-aspects-of-a-cgmp-continuous-drug-substance-process-and-contrasts-with-continuous-drug-product-10478
https://virtual.ispe.org/p/s/emerging-technologies-in-drug-delivery-combination-products-drivers-and-limiters-10479
https://virtual.ispe.org/p/s/sustainable-biomanufacturing-tools-and-objections-10480
https://virtual.ispe.org/p/s/achieving-decarbonization-and-resilience-with-microgrids-10481
https://virtual.ispe.org/p/s/elevatebio-basecamp-redefining-biomanufacturing-and-agile-scaling-of-operations-10482
https://virtual.ispe.org/p/s/building-an-in-house-cell-and-gene-therapy-manufacturing-facility-during-the-pandemic-10483
https://virtual.ispe.org/p/s/biopharmaceutical-manufacturing-facilities-of-the-future-looking-forward-looking-backward-10484
https://virtual.ispe.org/p/s/the-importance-of-manufacturing-in-cell-and-gene-therapy-development-10485
https://virtual.ispe.org/p/s/innovation-in-manufacturing-to-address-future-pandemics-10486
https://virtual.ispe.org/p/s/multi-modalilty-manufacturing-a-cdmo-perspective-10487
https://virtual.ispe.org/p/s/welcome-message-from-president-and-ceo-of-ispe-10488
https://virtual.ispe.org/p/s/cost-of-capital-for-fof-10489
https://virtual.ispe.org/p/s/aseptic-risk-mitigation-strategies-for-atmps-10490
https://virtual.ispe.org/p/s/islands-in-the-work-stream-10492
https://virtual.ispe.org/p/s/q-and-a-with-speakers-track-1-digital-transformation-and-pharma-40-10493
https://virtual.ispe.org/p/s/q-and-a-with-speakers-track-3-cell-and-gene-therapy-10497
https://virtual.ispe.org/p/s/q-and-a-with-speakers-track-4-emerging-technologies-part-1-10498
https://virtual.ispe.org/p/s/hhs-ibx-building-the-facilities-that-will-ensure-our-future-10499
https://virtual.ispe.org/p/s/executive-forum-dinner-presentation-to-begin-at-720-pm-10500
https://virtual.ispe.org/p/s/innovating-your-career-presented-by-ispe-women-in-pharma-10501
https://virtual.ispe.org/p/s/innovating-to-reinvent-medicine-for-a-healthier-world-10502
https://virtual.ispe.org/p/s/pharma-40-6th-survey-latest-results-and-trends-10504
https://virtual.ispe.org/p/s/faster-project-delivery-using-data-driven-enabling-tools-10509
https://virtual.ispe.org/p/s/q-and-a-with-speakers-track-6-emerging-technologies-part-2-10510
https://virtual.ispe.org/p/s/q-and-a-with-speakers-track-5-facility-design-and-construction-10511
https://virtual.ispe.org/p/s/introduction-to-nasaac-the-role-of-regional-councils-in-ispe-membership-10513
https://virtual.ispe.org/p/s/utility-analytics-unlocking-the-potential-of-bas-data-10515
https://virtual.ispe.org/p/s/panel-discussion-10516
https://virtual.ispe.org/p/s/facility-of-the-future-considerations-planning-and-realization-10517
https://virtual.ispe.org/p/s/precision-in-time-delivering-results-in-urgency-10518
https://virtual.ispe.org/p/cf/2023-ispe-aseptic-conference-10519
https://virtual.ispe.org/p/s/welcome-and-opening-keynote-10533
https://virtual.ispe.org/p/s/concurrent-session-manufacturing-case-studies-part-1-10537
https://virtual.ispe.org/p/s/concurrent-session-process-control-and-quality-risk-management-10542
https://virtual.ispe.org/p/s/concurrent-session-robotics-10545
https://virtual.ispe.org/p/s/concurrent-session-manufacturing-case-studies-part-2-10546
https://virtual.ispe.org/p/s/concurrent-session-contamination-control-10553
https://virtual.ispe.org/p/s/concurrent-session-atmpcell-and-gene-therapies-10558
https://virtual.ispe.org/p/s/industry-panel-annex-1-implementation-strategies-10560
https://virtual.ispe.org/p/s/keynote-session-10564
https://virtual.ispe.org/p/s/concurrent-session-new-technologies-10568
https://virtual.ispe.org/p/s/concurrent-session-microbiology-cleaning-and-training-10570
https://virtual.ispe.org/p/s/concurrent-session-decontamination-and-single-use-systems-10576
https://virtual.ispe.org/p/s/regulatory-panel-10580
https://virtual.ispe.org/p/s/concurrent-session-process-control-and-quality-risk-management-10591
https://virtual.ispe.org/p/s/how-to-reduce-the-risk-of-contamination-in-drug-manufacturing-group-discussion-10592
https://virtual.ispe.org/p/s/barrier-systems-in-annex-1-rabs-and-isolators-group-discussion-10593
https://virtual.ispe.org/p/cf/2023-ispe-europe-annual-conference-10594
https://virtual.ispe.org/p/s/journey-of-a-medical-device-company-to-digital-transformation-and-operational-excellence-10607
https://virtual.ispe.org/p/s/fighting-the-pandemic-with-vaccines-biomedicines-and-high-performance-ivds-10608
https://virtual.ispe.org/p/s/european-commissions-hera-initiatives-on-pandemic-preparedness-10609
https://virtual.ispe.org/p/s/emas-role-in-protecting-public-health-in-times-of-crisis-10610
https://virtual.ispe.org/p/s/realizing-supply-chain-resiliency-through-a-commitment-to-quality-10611
https://virtual.ispe.org/p/s/innovation-journey-from-lighthouse-to-lightbar-10612
https://virtual.ispe.org/p/s/2023-facility-of-the-year-award-foya-category-winner-announcements-and-programme-overview-10613
https://virtual.ispe.org/p/s/annex-1-overview-what-is-new-10614
https://virtual.ispe.org/p/s/foya-2022-category-winners-for-social-impact-and-project-execution-janssen-biologics-bv-location-leiden-the-netherlands-project-vaccine-launch-facility-vlf-expansion-10615
https://virtual.ispe.org/p/s/sap-batch-release-hub-one-central-cockpit-for-all-batch-releases-to-support-pharma-40-10616
https://virtual.ispe.org/p/s/a-cdmo-perspective-towards-the-annex-1-compliance-10617
https://virtual.ispe.org/p/s/foya-2022-category-winner-for-supply-chain-takeda-pharmaceuticals-international-ag-project-alofisel-global-program-10618
https://virtual.ispe.org/p/s/enhancing-digitalisation-across-supply-chain-10619
https://virtual.ispe.org/p/s/gamp-r-5-second-edition-an-overview-critical-thinking-for-smarter-validation-10620
https://virtual.ispe.org/p/s/ich-q10-supporting-advancing-pharmaceutical-quality-and-pharma-40-digital-maturity-10621
https://virtual.ispe.org/p/s/use-of-isa-388-recipes-in-digital-transformation-10622
https://virtual.ispe.org/p/s/digitization-in-cleanrooms-from-a-hardware-and-annex-1-viewpoint-10623
https://virtual.ispe.org/p/s/foya-2022-category-winner-for-pharma-40-takeda-pharmaceuticals-international-ag-location-singen-germany-project-tasiva-10624
https://virtual.ispe.org/p/s/briefing-on-eu-fluoropolymer-ban-facing-pharma-manufacturing-facilities-in-2027-10625
https://virtual.ispe.org/p/s/understanding-fdas-csa-guidance-in-the-context-of-current-regulations-and-gamp-r-10626
https://virtual.ispe.org/p/s/advantages-of-diversity-equity-and-inclusion-sponsored-by-ispe-women-in-pharma-10627
https://virtual.ispe.org/p/s/pharma-40-at-the-cdmo-psm-digitalised-aseptic-gmp-production-with-paperless-process-for-100-percent-traceability-10628
https://virtual.ispe.org/p/s/introduction-to-building-information-modelling-bim-application-use-and-cost-10629
https://virtual.ispe.org/p/s/how-data-mapping-helps-for-pharma-40-10630
https://virtual.ispe.org/p/s/risk-based-human-factor-control-strategy-how-to-combine-in-depth-analysis-of-human-errors-with-high-end-simulators-a-case-study-within-j-and-j-10631
https://virtual.ispe.org/p/s/panel-discussion-on-building-information-modelling-bim-10633
https://virtual.ispe.org/p/s/unified-name-space-deployment-to-a-pharmaceutical-environment-10634
https://virtual.ispe.org/p/s/business-value-with-data-driven-services-10635
https://virtual.ispe.org/p/s/cyber-security-context-and-use-case-of-a-self-assessment-tool-by-ispegamp-italy-affiliate-10636
https://virtual.ispe.org/p/s/pharma-40-plug-and-produce-and-the-digital-twin-10637
https://virtual.ispe.org/p/s/new-ispe-containment-good-practice-guide-gmp-and-occupational-safety-requirements-working-with-high-potent-substances-10638
https://virtual.ispe.org/p/s/gamp-r-5-second-edition-data-integrity-computer-software-assurance-csa-workshop-10639
https://virtual.ispe.org/p/s/current-state-of-pharma-40-facility-design-10640
https://virtual.ispe.org/p/s/high-potent-continuous-manufacturing-10641
https://virtual.ispe.org/p/s/agile-vs-traditional-pm-a-comparison-10642
https://virtual.ispe.org/p/s/blockchain-application-in-pharma-10644
https://virtual.ispe.org/p/s/osd-continuous-manufacturing-platform-to-technology-current-and-future-good-practices-from-an-owners-and-engineers-perspective-10645
https://virtual.ispe.org/p/s/organizational-development-during-the-digital-maturity-journey-10646
https://virtual.ispe.org/p/s/good-engineering-practice-accelerating-project-delivery-10647
https://virtual.ispe.org/p/s/blockchain-and-smart-pharmaceutical-manufacturing-10649
https://virtual.ispe.org/p/s/nextgen-knowledge-management-a-catalyst-for-realizing-digital-value-10650
https://virtual.ispe.org/p/s/is-re-shoring-of-apis-and-fdfs-finished-dosage-forms-to-europe-still-possible-10651
https://virtual.ispe.org/p/s/cell-therapy-facility-project-execution-challenges-and-lessons-learned-10655
https://virtual.ispe.org/p/s/emerging-leader-hackathon-winner-presentation-and-closing-remarks-10656
https://virtual.ispe.org/p/s/welcome-10697
https://virtual.ispe.org/p/s/international-co-operation-harmonisation-and-reliance-in-gmp-10698
https://virtual.ispe.org/p/s/mercks-approach-to-innovation-and-digital-transformation-10699
https://virtual.ispe.org/p/s/data-as-corporation-asset-10700
https://virtual.ispe.org/p/s/how-to-make-supply-chains-resilient-10701
https://virtual.ispe.org/p/s/biotechnology-what-about-omics-10703
https://virtual.ispe.org/p/s/remarks-from-the-conference-chairs-10704
https://virtual.ispe.org/p/s/pharma-40-6th-survey-deep-dive-10705
https://virtual.ispe.org/p/s/baseline-guide-ispe-pharma-40-10706
https://virtual.ispe.org/p/s/gamp-5-r-second-edition-overview-themes-and-objectives-10707
https://virtual.ispe.org/p/s/the-future-of-manufacturing-quality-in-pharma-10708
https://virtual.ispe.org/p/s/innovation-and-mhra-work-10709
https://virtual.ispe.org/p/s/digital-transformation-journey-of-pharma-development-labs-10710
https://virtual.ispe.org/p/s/exploring-the-transformation-in-digital-transformation-10711
https://virtual.ispe.org/p/s/q-and-a-and-closing-remarks-10712
https://virtual.ispe.org/p/s/cmo-as-a-platform-for-geographic-flexibility-10714
https://virtual.ispe.org/p/s/portfolio-optimisation-and-risk-management-10715
https://virtual.ispe.org/p/s/digital-project-development-achieving-optimal-decisions-10716
https://virtual.ispe.org/p/s/how-to-implement-a-platform-historian-10717
https://virtual.ispe.org/p/s/gamp-r-5-second-edition-and-beyond-a-holistic-approach-to-ai-10721
https://virtual.ispe.org/p/s/paperless-validation-in-an-agile-environment-10722
https://virtual.ispe.org/p/s/risk-based-digital-validation-approach-for-sap-10723
https://virtual.ispe.org/p/s/gamp-r-5-second-edition-round-table-10724
https://virtual.ispe.org/p/s/welcome-by-ispe-ceo-and-president-10728
https://virtual.ispe.org/p/s/regulatory-panel-discussion-10729
https://virtual.ispe.org/p/s/digital-transformation-pharma-40-innovation-panel-discussion-10730
https://virtual.ispe.org/p/s/q-and-a-track-1-pharma-40-10731
https://virtual.ispe.org/p/s/a-word-from-the-ispe-foundation-10733
https://virtual.ispe.org/p/s/q-and-a-track-1-pharma-40-10734
https://virtual.ispe.org/p/cf/2023-ispe-biotechnology-conference-10735
https://virtual.ispe.org/p/s/the-digital-conundrum-10743
https://virtual.ispe.org/p/s/sustainability-in-biopharma-critical-utilities-10744
https://virtual.ispe.org/p/s/assessing-the-manufacturing-digital-thread-10745
https://virtual.ispe.org/p/s/dataspaces-a-new-paradigm-in-supply-chain-optimisation-10746
https://virtual.ispe.org/p/s/ai-solution-validation-for-environmental-monitoring-10747
https://virtual.ispe.org/p/s/monosource-and-single-use-technology-risk-10748
https://virtual.ispe.org/p/s/beyond-smart-factories-astrazenecas-global-operations-10749
https://virtual.ispe.org/p/s/patient-centric-specifications-for-biological-products-10750
https://virtual.ispe.org/p/s/self-learning-digital-twins-for-faster-time-to-market-10751
https://virtual.ispe.org/p/s/assessment-of-recombinant-factor-c-for-endotoxin-testing-10752
https://virtual.ispe.org/p/s/panel-discussion-with-all-speakers-from-track-1-10753
https://virtual.ispe.org/p/s/panel-discussion-with-all-speakers-from-track-2-10754
https://virtual.ispe.org/p/s/rapid-implementation-of-continuous-manufacturing-10755
https://virtual.ispe.org/p/s/cell-and-gene-therapy-critical-starting-material-establishing-release-specifications-for-plasmids-10756
https://virtual.ispe.org/p/s/boost-production-agility-by-tracking-daily-inventories-10757
https://virtual.ispe.org/p/s/design-considerations-for-atmp-manufacturing-facilities-10758
https://virtual.ispe.org/p/s/panel-discussion-with-speakers-from-track-6-part-2-10759
https://virtual.ispe.org/p/s/track-5-closing-remarks-and-adjourn-10760
https://virtual.ispe.org/p/s/track-6-closing-remarks-and-adjourn-10761
https://virtual.ispe.org/p/s/networking-dinner-10762
https://virtual.ispe.org/p/s/commercial-plasmid-manufacturing-10763
https://virtual.ispe.org/p/s/welcome-to-the-2023-biotechnology-conference-10764
https://virtual.ispe.org/p/s/ireland-enabling-biotech-innovation-and-future-success-10765
https://virtual.ispe.org/p/s/patient-access-through-innovation-10766
https://virtual.ispe.org/p/s/future-biotech-portfolio-challenges-in-translating-biotech-innovation-into-viable-therapeutics-10767
https://virtual.ispe.org/p/s/keys-to-realising-the-full-potential-of-advanced-therapies-10769
https://virtual.ispe.org/p/s/our-journey-from-manufacturing-to-smartfacturing-10770
https://virtual.ispe.org/p/s/the-importance-of-manufacturing-in-the-development-of-advanced-therapies-10771
https://virtual.ispe.org/p/s/pfas-reach-restriction-a-potential-eu-ban-on-use-of-fluoropolymers-10772
https://virtual.ispe.org/p/s/message-from-the-programme-chair-10773
https://virtual.ispe.org/p/s/tools-for-success-in-a-multinational-and-multigenerational-environment-sponsored-by-ispe-women-in-pharma-r-10778
https://virtual.ispe.org/p/s/regulation-of-atmp-manufacture-10779
https://virtual.ispe.org/p/s/2b-or-not-2b-readiness-for-the-ppq-of-a-cell-therapy-10780
https://virtual.ispe.org/p/s/from-hospital-to-commercial-manufacturing-10781
https://virtual.ispe.org/p/s/a-mechanistic-model-of-an-icb-process-10782
https://virtual.ispe.org/p/s/development-of-a-commercially-scalable-oncolytic-vaccine-production-process-for-viral-immunotherapy-10783
https://virtual.ispe.org/p/s/commercial-manufacturing-of-atmps-takeda-alofisel-case-study-10784
https://virtual.ispe.org/p/s/innovating-technology-to-meet-future-needs-in-biopharma-10785
https://virtual.ispe.org/p/s/flexible-and-multi-modal-atmp-facilities-10787
https://virtual.ispe.org/p/s/application-of-lean-sigma-to-pharmaceutical-manufacturing-10788
https://virtual.ispe.org/p/s/processing-of-atmps-at-a-german-cdmo-scale-up-of-a-viral-vector-fill-and-finish-project-from-bench-top-to-fully-automated-10789
https://virtual.ispe.org/p/s/characterisation-and-modeling-biopharmaceutical-processes-10790
https://virtual.ispe.org/p/s/design-of-a-biomanufacturing-and-sterile-fill-finish-facility-for-atmps-yescarta-case-study-10791
https://virtual.ispe.org/p/s/digital-twins-a-generic-methodology-along-the-bioproduct-life-cycle-10792
https://virtual.ispe.org/p/s/panel-discussion-with-all-speakers-from-track-3-10793
https://virtual.ispe.org/p/s/panel-discussion-with-all-speakers-from-track-4-10794
https://virtual.ispe.org/p/s/how-to-combine-multiple-modalities-with-speed-and-agility-10796
https://virtual.ispe.org/p/s/spikevax-and-establishment-of-a-vaccine-platform-10797
https://virtual.ispe.org/p/s/fast-track-delivery-of-a-hybrid-suss-process-10798
https://virtual.ispe.org/p/s/dna-matrices-for-mrna-synthesis-10799
https://virtual.ispe.org/p/s/standardization-leads-to-agility-leads-to-speed-10800
https://virtual.ispe.org/p/s/downstream-process-development-for-high-productivity-purification-of-plasmid-dna-10801
https://virtual.ispe.org/p/s/panel-discussion-with-speakers-from-track-6-part-1-10802
https://virtual.ispe.org/p/cf/2023-ispe-annual-meeting-and-expo-10804
https://virtual.ispe.org/p/s/workshop-holistic-digital-pharma-40-maturity-assessment-10829
https://virtual.ispe.org/p/s/workshop-ich-q9r1-and-quality-risk-management-10830
https://virtual.ispe.org/p/s/workshop-development-of-a-contamination-control-strategy-10831
https://virtual.ispe.org/p/s/workshop-designing-and-operations-of-a-flexible-mfg-facility-10832
https://virtual.ispe.org/p/s/workshop-oee-and-ml-for-process-optimization-using-seeq-10833
https://virtual.ispe.org/p/s/workshop-essentials-for-leadership-development-10834
https://virtual.ispe.org/p/s/workshop-innovation-and-sustainable-development-of-biopharma-10835
https://virtual.ispe.org/p/s/facility-of-the-year-awards-celebratory-reception-and-banquet-10837
https://virtual.ispe.org/p/s/welcome-and-opening-remarks-10838
https://virtual.ispe.org/p/s/navigating-uncertainty-the-power-of-resilient-supply-chains-10839
https://virtual.ispe.org/p/s/the-pursuit-of-excellence-in-novel-therapeutic-development-10840
https://virtual.ispe.org/p/s/science-patient-and-the-role-engineering-plays-as-a-catalyst-10841
https://virtual.ispe.org/p/s/conference-highlights-10842
https://virtual.ispe.org/p/s/csa-opportunities-for-gamp-5-2nd-edition-and-21-cfr-part-11-10843
https://virtual.ispe.org/p/s/environmental-sustainability-operations-and-products-10844
https://virtual.ispe.org/p/s/global-drug-shortage-prevention-and-future-directions-10845
https://virtual.ispe.org/p/s/therapy-development-and-facility-design-for-market-readiness-10846
https://virtual.ispe.org/p/s/combination-products-success-in-advanced-therapies-10847
https://virtual.ispe.org/p/s/membership-meeting-and-awards-lunch-open-to-all-attendees-10848
https://virtual.ispe.org/p/s/the-holistic-digital-transformation-the-pharma-40-journey-10849
https://virtual.ispe.org/p/s/design-and-implementation-of-systems-and-facilities-10850
https://virtual.ispe.org/p/s/supply-chain-resilience-and-transformational-change-10851
https://virtual.ispe.org/p/s/technology-advancement-10852
https://virtual.ispe.org/p/s/modernizing-regulatory-cmc-submissions-enabling-change-10853
https://virtual.ispe.org/p/s/application-of-pat-for-real-world-gmp-operations-10854
https://virtual.ispe.org/p/s/quality-risk-management-applications-for-qualification-10855
https://virtual.ispe.org/p/s/innovations-and-best-practices-in-sustainable-development-10856
https://virtual.ispe.org/p/s/transformation-into-atmp-10857
https://virtual.ispe.org/p/s/global-harmonization-to-advance-innovation-10858
https://virtual.ispe.org/p/s/opening-remarks-10859
https://virtual.ispe.org/p/s/ispe-southwest-chapter-presidents-welcome-10860
https://virtual.ispe.org/p/s/ispe-foundation-greeting-10861
https://virtual.ispe.org/p/s/be-the-white-crayon-a-patient-perspective-10862
https://virtual.ispe.org/p/s/reinventing-partnerships-and-medicine-for-a-healthier-world-10863
https://virtual.ispe.org/p/s/closing-announcements-10864
https://virtual.ispe.org/p/s/leveraging-ml-for-process-efficiency-and-compliance-10865
https://virtual.ispe.org/p/s/advancements-in-drug-development-and-equipment-design-10866
https://virtual.ispe.org/p/s/supply-chain-fragility-and-the-impact-on-patient-care-10867
https://virtual.ispe.org/p/s/atmp-lifecycle-10868
https://virtual.ispe.org/p/s/quality-management-maturity-in-action-10869
https://virtual.ispe.org/p/s/the-digital-journey-10871
https://virtual.ispe.org/p/s/achieving-net-zero-in-pharma-manufacturing-10872
https://virtual.ispe.org/p/s/product-development-supply-chain-security-and-mfg-excellence-10873
https://virtual.ispe.org/p/s/advances-in-atmp-10874
https://virtual.ispe.org/p/s/updates-on-ich-quality-topics-ich-q12-q14-and-m4q-10875
https://virtual.ispe.org/p/s/2023-ispe-hackathon-winning-team-10876
https://virtual.ispe.org/p/s/unveiling-las-vegas-a-frontier-of-innovation-10877
https://virtual.ispe.org/p/s/trends-supporting-access-to-medicines-for-patients-10878
https://virtual.ispe.org/p/s/global-regulatory-town-hall-10879
https://virtual.ispe.org/p/s/developing-a-workforce-for-the-future-10880
https://virtual.ispe.org/p/s/closing-words-and-adjournment-10881
https://virtual.ispe.org/p/s/innovation-and-preservation-positive-environmental-impact-10968
https://virtual.ispe.org/p/s/delivering-sustainable-projects-10969
https://virtual.ispe.org/p/s/the-potential-of-modular-production-with-zenon-and-mtp-10970
https://virtual.ispe.org/p/s/future-labs-10971
https://virtual.ispe.org/p/s/fireside-chat-with-robert-califf-md-and-tom-hartman-ispe-ceo-10972
https://virtual.ispe.org/p/cf/2023-ispe-pharma-40-and-annex-1-conference-10973
https://virtual.ispe.org/p/s/ispe-student-and-recent-graduate-orientation-10980
https://virtual.ispe.org/p/s/air-speed-at-working-position-at-working-level-10982
https://virtual.ispe.org/p/s/advancing-pharmaceutical-quality-the-knowledge-enabled-organization-10983
https://virtual.ispe.org/p/s/validation-and-qualification-approach-in-new-annex-1-10984
https://virtual.ispe.org/p/s/organizational-development-as-priority-for-successful-digital-transformation-fireside-chat-10985
https://virtual.ispe.org/p/s/end-to-end-ccs-in-atmp-through-advanced-risk-profiling-10986
https://virtual.ispe.org/p/s/advanced-data-driven-process-performance-and-product-quality-monitoring-system-pppqms-for-real-time-quality-decisions-10987
https://virtual.ispe.org/p/s/case-study-on-implementation-of-a-contamination-control-strategy-10988
https://virtual.ispe.org/p/s/navigating-quality-maturity-and-digital-transformation-to-create-a-culture-beyond-compliance-10989
https://virtual.ispe.org/p/s/interpretation-of-eu-gmp-annex-1-for-atmps-10990
https://virtual.ispe.org/p/s/application-validation-and-verification-of-end-to-end-procecess-digital-twins-10991
https://virtual.ispe.org/p/s/panel-discussion-with-speakers-from-track-1-10992
https://virtual.ispe.org/p/s/next-gen-pharma-quality-management-unleashing-the-power-of-modular-approach-10993
https://virtual.ispe.org/p/s/leadership-agility-adapting-to-the-evolving-landscape-of-the-industry-powered-and-led-by-ispe-women-in-pharma-r-10994
https://virtual.ispe.org/p/s/integrating-a-prefilled-syringe-filling-line-into-a-legacy-facility-10995
https://virtual.ispe.org/p/s/delivering-a-gpg-for-container-traceability-in-2024-10996
https://virtual.ispe.org/p/s/aps-risk-based-compliant-and-cost-effective-approach-10997
https://virtual.ispe.org/p/s/predictive-inventory-in-supply-chain-analytics-10998
https://virtual.ispe.org/p/s/impact-of-annex-1-on-blow-fill-seal-technology-10999
https://virtual.ispe.org/p/s/applying-pharma-40-to-expand-access-to-biotherapeutics-11000
https://virtual.ispe.org/p/s/gap-assessment-strategy-for-the-new-annex-1-11001
https://virtual.ispe.org/p/s/roadmap-to-deliver-real-value-from-pharma-40-11002
https://virtual.ispe.org/p/s/automation-of-formats-loading-line-for-gmp-freeze-dryers-11003
https://virtual.ispe.org/p/s/all-digital-engineering-to-operations-11004
https://virtual.ispe.org/p/s/panel-discussion-with-speakers-from-track-3-11005
https://virtual.ispe.org/p/s/panel-discussion-with-speakers-from-track-4-11006
https://virtual.ispe.org/p/s/annex-1-aseptic-powder-filling-challenges-11007
https://virtual.ispe.org/p/s/analysis-of-30-plus-pharma-40-use-cases-enabling-technologies-benefits-challenges-and-lessons-learned-11008
https://virtual.ispe.org/p/s/annex-1-implementation-a-usa-cmo-perspective-11009
https://virtual.ispe.org/p/s/improving-aseptic-interventions-with-ai-supported-monitoring-review-of-a-pilot-in-a-gmp-produciton-11010
https://virtual.ispe.org/p/s/aseptic-f-and-f-of-soft-mist-inhaler-project-experiences-11011
https://virtual.ispe.org/p/s/flexible-line-and-lean-logistics-for-packaging-11012
https://virtual.ispe.org/p/s/multi-product-fill-and-finish-and-lyophilization-11013
https://virtual.ispe.org/p/s/learnings-from-using-deep-learning-in-pharma-manufacturing-visual-gmp-inspection-11014
https://virtual.ispe.org/p/s/unique-bfpc-for-real-time-viable-air-monitoring-11015
https://virtual.ispe.org/p/s/lean-compliant-and-digital-quality-control-lab-11016
https://virtual.ispe.org/p/s/panel-discussion-with-speakers-from-track-5-and-closing-remarks-11017
https://virtual.ispe.org/p/s/panel-discussion-with-speakers-from-track-6-and-closing-remarks-11018
https://virtual.ispe.org/p/s/welcome-to-the-2023-ispe-pharma-40-and-annex1-conference-11021
https://virtual.ispe.org/p/s/a-national-competent-authority-perspective-of-the-legislative-momentum-11022
https://virtual.ispe.org/p/s/advancing-digitalisation-in-manufacturing-eu-initiatives-11023
https://virtual.ispe.org/p/s/quality-thinking-in-lightspeed-people-making-a-pandemic-vaccine-11024
https://virtual.ispe.org/p/s/ispe-foundation-11025
https://virtual.ispe.org/p/s/regulatory-panel-discussion-practical-applications-of-current-standards-and-regulations-in-the-context-of-digitalization-11026
https://virtual.ispe.org/p/s/digital-transformation-journey-lessons-learned-from-the-pharma-40-baseline-guide-11027
https://virtual.ispe.org/p/s/7th-annual-ispe-pharma-40-survey-application-in-industry-11028
https://virtual.ispe.org/p/s/message-from-conference-chairs-11029
https://virtual.ispe.org/p/s/gamp-r-basic-principles-two-day-training-course-day-1-11032
https://virtual.ispe.org/p/s/gamp-r-basic-principles-two-day-training-course-day-2-11033
https://virtual.ispe.org/p/cf/2024-ispe-facilities-of-the-future-conference-11034
https://virtual.ispe.org/p/s/single-use-technology-standardization-a-case-study-11048
https://virtual.ispe.org/p/s/sustainability-in-facility-design-11049
https://virtual.ispe.org/p/s/nih-center-for-alzheimers-research-and-speed-to-open-11050
https://virtual.ispe.org/p/s/clean-by-design-for-efficiency-and-sustainability-11051
https://virtual.ispe.org/p/s/a-flexible-and-future-proof-cgmp-facility-for-the-unknown-11052
https://virtual.ispe.org/p/s/sustainability-assessement-on-cu-method-and-case-study-11053
https://virtual.ispe.org/p/s/rapid-drug-substance-facility-end-2-end-modular-delivery-11054
https://virtual.ispe.org/p/s/gileads-la-vernes-energy-reduction-experience-11055
https://virtual.ispe.org/p/s/designing-a-gene-therapy-factory-that-flexes-for-the-future-11056
https://virtual.ispe.org/p/s/powering-biotech-inside-an-all-electric-facility-11057
https://virtual.ispe.org/p/s/implementing-the-new-biomanufacturing-facilities-guide-panel-discussion-11058
https://virtual.ispe.org/p/s/sustainable-water-for-injection-steam-less-wfi-for-the-genentech-clinical-supply-center-11059
https://virtual.ispe.org/p/s/executive-forum-panel-discussion-11060
https://virtual.ispe.org/p/s/virtual-twins-asset-induction-and-facility-management-11061
https://virtual.ispe.org/p/s/ionized-hydrogen-peroxide-system-11062
https://virtual.ispe.org/p/s/digital-shopfloor-and-virtual-facility-sifi-or-reality-11063
https://virtual.ispe.org/p/s/enabling-operational-excellence-for-aseptic-practices-in-sterile-manufacturing-11064
https://virtual.ispe.org/p/s/bridging-the-translational-gap-wheeler-bios-journey-in-digitalized-cdmo-services-11065
https://virtual.ispe.org/p/s/how-generative-ai-is-changing-how-we-think-about-manufacturing-11066
https://virtual.ispe.org/p/s/pioneering-growth-through-pharma-40-11067
https://virtual.ispe.org/p/s/creating-the-workforce-of-the-future-11068
https://virtual.ispe.org/p/s/strategies-to-accelerate-pharma-40-adoption-case-study-11069
https://virtual.ispe.org/p/s/unprecedented-speed-through-innovation-how-amgen-ohio-rose-from-the-ground-up-in-record-time-11070
https://virtual.ispe.org/p/s/a-look-inside-the-world-of-integrated-digital-operations-11071
https://virtual.ispe.org/p/s/eagile-a-transformation-driving-innovation-in-manufacturing-11072
https://virtual.ispe.org/p/s/welcome-to-the-2024-ispe-facilities-of-the-future-conference-11073
https://virtual.ispe.org/p/s/end-to-end-supply-chain-digital-transformation-11074
https://virtual.ispe.org/p/s/building-a-workplace-of-the-future-within-a-research-site-11075
https://virtual.ispe.org/p/s/welcome-from-the-conference-chair-11076
https://virtual.ispe.org/p/s/a-word-from-the-ispe-foundation-11077
https://virtual.ispe.org/p/s/remarks-from-the-san-franciscobay-area-chapter-11081
https://virtual.ispe.org/p/s/facility-of-the-future-design-philosophy-tensions-for-genentechs-new-clinical-supply-center-11082
https://virtual.ispe.org/p/s/expanding-globally-while-achieving-net-zero-11083
https://virtual.ispe.org/p/s/closing-remarks-11084
https://virtual.ispe.org/p/s/workforce-of-the-future-the-influence-and-importance-of-people-11085
https://virtual.ispe.org/p/s/beyond-cgmp-proactive-quality-principles-today-for-facilities-of-tomorrow-11087
https://virtual.ispe.org/p/s/dummy-11088
https://virtual.ispe.org/p/cf/2024-ispe-aseptic-conference-11089
https://virtual.ispe.org/p/s/aseptic101-11098
https://virtual.ispe.org/p/s/registration-open-11099
https://virtual.ispe.org/p/s/welcome-to-the-2024-ispe-aseptic-conference-11100
https://virtual.ispe.org/p/s/implementation-of-annex-1-gmp-inspectors-view-11101
https://virtual.ispe.org/p/s/revised-annex-1-fit-for-future-11102
https://virtual.ispe.org/p/s/welcome-from-the-conference-chair-11103
https://virtual.ispe.org/p/s/break-11104
https://virtual.ispe.org/p/s/parametric-release-a-smart-way-for-sterile-products-11105
https://virtual.ispe.org/p/s/seal-tightness-drones-to-support-container-closure-integrity-assurance-11106
https://virtual.ispe.org/p/s/gloveless-isolators-11107
https://virtual.ispe.org/p/s/ccs-implementation-for-sterilized-production-equipment-11108
https://virtual.ispe.org/p/s/achieving-compliance-validating-vr-training-in-pharma-11109
https://virtual.ispe.org/p/s/steam-sterilization-of-stoppers-and-biological-validation-11110
https://virtual.ispe.org/p/s/operator-aseptic-qualification-for-manual-processes-11111
https://virtual.ispe.org/p/s/lunch-11112
https://virtual.ispe.org/p/s/lyophillization-by-aseptic-spray-freeze-drying-11113
https://virtual.ispe.org/p/s/integrate-biodecontamination-systems-for-sustainability-11114
https://virtual.ispe.org/p/s/gloveless-isolators-panel-11115
https://virtual.ispe.org/p/s/environmental-considerations-for-lyophilization-11116
https://virtual.ispe.org/p/s/life-cycle-assessment-of-pharmaceutical-glass-packaging-11117
https://virtual.ispe.org/p/s/radiopharmaceutical-dispensing-systems-11118
https://virtual.ispe.org/p/s/elevating-sustainability-in-pharmaceutical-water-systems-11119
https://virtual.ispe.org/p/s/automated-radiopharmaceutical-fill-finish-line-challenges-11120
https://virtual.ispe.org/p/s/sustainability-in-pharma-how-to-achieve-co2-net-zero-goal-11121
https://virtual.ispe.org/p/s/break-11122
https://virtual.ispe.org/p/s/winding-path-to-success-where-titles-salaries-and-culture-intersect-11123
https://virtual.ispe.org/p/s/welcome-reception-in-the-exhibition-area-11124
https://virtual.ispe.org/p/s/registration-open-11125
https://virtual.ispe.org/p/s/opening-remarks-day-2-11126
https://virtual.ispe.org/p/s/dach-affiliate-greeting-11127
https://virtual.ispe.org/p/s/ispe-foundation-greeting-11128
https://virtual.ispe.org/p/s/an-industry-association-perspective-11129
https://virtual.ispe.org/p/s/advantages-and-challenges-for-the-pharmaceutical-industry-of-upgraded-guidelines-for-aseptic-process-annex1-11130
https://virtual.ispe.org/p/s/break-11132
https://virtual.ispe.org/p/s/increasing-assurance-in-h202-biodecontamination-with-eis-11133
https://virtual.ispe.org/p/s/revolutionizing-microbiological-monitoring-11134
https://virtual.ispe.org/p/s/how-to-approach-the-deliverable-of-flexibility-demanded-11135
https://virtual.ispe.org/p/s/validation-of-a-fully-gloveless-aseptic-isolator-11136
https://virtual.ispe.org/p/s/next-generation-of-aseptic-filling-according-to-annex-1-11137
https://virtual.ispe.org/p/s/cell-therapy-bmss-value-stream-transformation-11138
https://virtual.ispe.org/p/s/hydrogen-peroxide-detection-in-pharmaceutical-water-11139
https://virtual.ispe.org/p/s/lunch-11140
https://virtual.ispe.org/p/s/implementation-of-biofluorescence-particle-counters-to-replace-traditional-em-methods-at-novo-nordisk-as-11141
https://virtual.ispe.org/p/s/navigating-the-future-in-aseptic-drug-manufacture-11142
https://virtual.ispe.org/p/s/innovations-on-new-cmo-aseptic-filling-line-11143
https://virtual.ispe.org/p/s/impact-of-annex-1-on-current-ispe-sterile-baseline-guide-11144
https://virtual.ispe.org/p/s/data-driven-process-optimization-using-digital-twins-11145
https://virtual.ispe.org/p/s/maximizing-gene-therapy-doses-for-patients-11146
https://virtual.ispe.org/p/s/ichq9r1-compliant-risk-assessment-for-ccs-11147
https://virtual.ispe.org/p/s/high-concentrated-vphp-for-continuous-decontamination-11148
https://virtual.ispe.org/p/s/maintaining-control-in-point-of-care-aseptic-processing-for-atmps-11149
https://virtual.ispe.org/p/s/transition-break-11150
https://virtual.ispe.org/p/s/regulatory-panel-annex-1-inspection-learnings-11151
https://virtual.ispe.org/p/s/closing-words-and-adjournment-11152
https://virtual.ispe.org/p/s/the-impact-of-annex-1-on-air-visualization-studies-11153
https://virtual.ispe.org/p/s/airflow-visualization-using-smoke-to-make-things-clearer-11154
https://virtual.ispe.org/p/cf/2024-ispe-europe-annual-meeting-and-expo-11155
https://virtual.ispe.org/p/s/digital-transformation-practical-implementation-of-new-tecnologies-11159
https://virtual.ispe.org/p/s/validation-of-saas-cloud-platforms-for-pharma-industry-11160
https://virtual.ispe.org/p/s/welcome-to-the-ispe-europe-annual-conference-11162
https://virtual.ispe.org/p/s/remarks-from-the-executive-chair-11163
https://virtual.ispe.org/p/s/commercializing-autologous-cell-therapies-11164
https://virtual.ispe.org/p/s/the-magic-of-mushrooms-11165
https://virtual.ispe.org/p/s/welcome-from-the-ispe-vice-president-of-european-operations-11166
https://virtual.ispe.org/p/s/strengthening-value-chain-resilience-11167
https://virtual.ispe.org/p/s/2024-facility-of-the-year-award-foya-category-winners-11168
https://virtual.ispe.org/p/s/fda-regulatory-keynote-11169
https://virtual.ispe.org/p/s/operations-excellence-meets-digital-11170
https://virtual.ispe.org/p/s/regulatory-panel-11171
https://virtual.ispe.org/p/s/a-word-from-the-ispe-foundation-11172
https://virtual.ispe.org/p/s/advancing-digitalisation-in-manufacturing-eu-initiatives-11174
https://virtual.ispe.org/p/s/remarks-from-the-conference-chair-and-iberia-affiliate-11175
https://virtual.ispe.org/p/s/a-conversation-with-lars-fruergaard-jorgensen-novo-nordisk-11176
https://virtual.ispe.org/p/s/regulatory-preparedness-for-digital-transformation-11177
https://virtual.ispe.org/p/s/charting-pharmas-digital-journey-insights-from-the-pharma-40-7th-edition-study-11178
https://virtual.ispe.org/p/s/resilient-project-execution-design-assist-model-success-11179
https://virtual.ispe.org/p/s/inspection-case-studies-from-tga-11180
https://virtual.ispe.org/p/s/hearing-from-regulators-11181
https://virtual.ispe.org/p/s/takedas-pharma-40-journey-engineering-use-cases-11182
https://virtual.ispe.org/p/s/ispe-baseline-guide-on-biopharmaceutical-manufacturing-11183
https://virtual.ispe.org/p/s/inspection-case-study-from-mhra-11184
https://virtual.ispe.org/p/s/advances-in-gene-editing-and-facility-design-implications-11185
https://virtual.ispe.org/p/s/ai-applications-in-quality-management-11186
https://virtual.ispe.org/p/s/validation-of-cloud-computing-saas-11187
https://virtual.ispe.org/p/s/closed-processing-at-risk-a-regulatory-view-on-closed-systems-11188
https://virtual.ispe.org/p/s/pfas-and-titanium-dioxide-where-are-we-11189
https://virtual.ispe.org/p/s/ai-as-an-enabler-for-automated-digital-cryo-em-image-processing-11190
https://virtual.ispe.org/p/s/best-practices-for-digital-batch-records-ebr-in-pharma-40-11191
https://virtual.ispe.org/p/s/de-risking-your-aseptic-operation-via-better-design-from-a-regulator-view-11192
https://virtual.ispe.org/p/s/project-governance-key-for-project-success-11193
https://virtual.ispe.org/p/s/leveraging-gamp-r-5-for-medical-devices-11194
https://virtual.ispe.org/p/s/leveraging-digital-to-improve-manufacturing-processes-11195
https://virtual.ispe.org/p/s/impact-analysis-of-project-risks-on-investment-11196
https://virtual.ispe.org/p/s/de-risking-your-aseptic-operation-via-better-design-from-the-industry-view-11197
https://virtual.ispe.org/p/s/drug-shortage-prevention-where-are-we-11198
https://virtual.ispe.org/p/s/implementing-the-use-of-collaborative-platforms-and-360-degree-cameras-11199
https://virtual.ispe.org/p/s/e-compliance-requirements-for-supplier-and-service-provider-11200
https://virtual.ispe.org/p/s/experience-with-risk-management-for-large-capex-projects-11201
https://virtual.ispe.org/p/s/annex-1-points-for-discussion-11202
https://virtual.ispe.org/p/s/panel-discussion-on-drug-shortages-11203
https://virtual.ispe.org/p/s/enhanced-process-yield-insights-through-ai-powered-data-analytics-11204
https://virtual.ispe.org/p/s/a-control-framework-to-limit-risk-of-ai-in-gxp-11205
https://virtual.ispe.org/p/s/speed-presentations-on-sustainability-cases-11206
https://virtual.ispe.org/p/s/famar-integrated-system-of-flash-audits-innovation-in-audit-11207
https://virtual.ispe.org/p/s/apq-guidance-and-capa-introduction-11208
https://virtual.ispe.org/p/s/unlocking-efficiency-and-flexibility-11209
https://virtual.ispe.org/p/s/ai-revolution-in-visual-inspection-use-case-with-csl-behring-11210
https://virtual.ispe.org/p/s/annex-1-and-aps-practical-approach-and-points-to-consider-11211
https://virtual.ispe.org/p/s/advancing-pharmaceutical-quality-cultural-excellence-11212
https://virtual.ispe.org/p/s/panel-discussion-on-sustainability-11213
https://virtual.ispe.org/p/s/how-generative-ai-is-impacting-pharmaceutical-manufacturing-11214
https://virtual.ispe.org/p/s/monitoring-of-a-validated-machine-learning-solution-11215
https://virtual.ispe.org/p/s/aseptic-transfers-of-rtu-containers-in-the-light-of-annex-1-11216
https://virtual.ispe.org/p/s/quality-risk-management-with-ich-q9r1-11217
https://virtual.ispe.org/p/s/achieving-value-through-digital-replication-11218
https://virtual.ispe.org/p/s/guidance-on-filter-integrity-testing-for-ds-manufacturing-11219
https://virtual.ispe.org/p/s/accommodating-multiple-atmp-modalities-in-the-same-facility-11220
https://virtual.ispe.org/p/s/computerized-systems-in-clinical-trials-11221
https://virtual.ispe.org/p/s/how-to-manage-capa-based-on-culture-excellence-and-qrm-11222
https://virtual.ispe.org/p/s/robotic-process-automation-to-enhance-individual-case-study-11223
https://virtual.ispe.org/p/s/the-future-of-process-simulation-for-modern-biopharma-plants-11224
https://virtual.ispe.org/p/s/demystifying-generative-ai-how-it-works-and-the-challenges-11225
https://virtual.ispe.org/p/s/gamp-guiding-data-integrity-via-data-stewardship-11227
https://virtual.ispe.org/p/s/improving-sustainability-by-empq-based-design-and-operation-11228
https://virtual.ispe.org/p/s/regulatory-insights-for-atmp-manufacturers-and-commercialization-11229
https://virtual.ispe.org/p/s/bridging-the-gap-healthcare-equity-in-the-digital-age-11230
https://virtual.ispe.org/p/s/hackathon-winner-presentation-11231
https://virtual.ispe.org/p/s/closing-remarks-11232
https://virtual.ispe.org/p/s/a-message-from-infarmed-11256
https://virtual.ispe.org/p/s/designing-an-efficient-predictable-global-post-approval-change-system-11257
https://virtual.ispe.org/p/s/drug-shortages-prevention-in-europe-where-we-are-11258
https://virtual.ispe.org/p/cf/2024-ispe-biotechnology-conference-11259
https://virtual.ispe.org/p/s/welcome-to-the-2024-ispe-biotechnology-conference-11261
https://virtual.ispe.org/p/s/message-from-the-ispe-boston-chapter-11262
https://virtual.ispe.org/p/s/healthcare-equality-technology-and-innovation-11263
https://virtual.ispe.org/p/s/from-nanotechnology-to-mrna-vaccines-11264
https://virtual.ispe.org/p/s/towards-individualized-medicine-11265
https://virtual.ispe.org/p/s/networking-break-in-the-expo-hall-11266
https://virtual.ispe.org/p/s/global-supply-chain-strategy-11267
https://virtual.ispe.org/p/s/potential-of-ai-in-pharmaceutical-manufacturing-11268
https://virtual.ispe.org/p/s/a-word-from-the-ispe-foundation-11269
https://virtual.ispe.org/p/s/message-from-the-conference-chair-11270
https://virtual.ispe.org/p/s/lunch-in-the-expo-hall-11271
https://virtual.ispe.org/p/s/reducing-manufacturings-environmental-footprint-11272
https://virtual.ispe.org/p/s/commitment-to-quality-through-management-maturity-11273
https://virtual.ispe.org/p/s/gsks-ecodesign-program-enabling-sustainability-improvement-11274
https://virtual.ispe.org/p/s/enterprise-maturity-11275
https://virtual.ispe.org/p/s/pfas-where-are-we-overview-of-the-pfas-situation-11276
https://virtual.ispe.org/p/s/quality-culture-in-the-pharmaceutical-industry-11277
https://virtual.ispe.org/p/s/networking-break-in-the-expo-hall-11278
https://virtual.ispe.org/p/s/quality-maturity-model-framework-construction-is-an-art-11279
https://virtual.ispe.org/p/s/green-reagents-transforming-therapeutic-production-11280
https://virtual.ispe.org/p/s/a-scientific-perspective-on-quality-management-maturity-11281
https://virtual.ispe.org/p/s/applying-the-biomanufacturing-facilities-baseline-guide-11282
https://virtual.ispe.org/p/s/the-role-of-leaders-in-quality-culture-11283
https://virtual.ispe.org/p/s/ispe-advancing-pharmaceutical-quality-apq-program-11284
https://virtual.ispe.org/p/s/welcome-reception-in-the-expo-hall-11285
https://virtual.ispe.org/p/s/women-in-pharma-r-ai-driven-efficiency-in-modern-workspaces-11286
https://virtual.ispe.org/p/s/good-practices-to-achieve-data-quality-and-data-maturity-11287
https://virtual.ispe.org/p/s/the-factory-of-the-future-a-holistic-implementation-11288
https://virtual.ispe.org/p/s/a-recipe-centric-approach-to-digital-technology-transfer-11289
https://virtual.ispe.org/p/s/how-gloveless-fill-and-finish-can-enable-a-scaleout-approach-11290
https://virtual.ispe.org/p/s/lights-out-car-t-manufacturing-at-reduced-cogs-11291
https://virtual.ispe.org/p/s/networking-break-in-the-expo-hall-11292
https://virtual.ispe.org/p/s/end-to-end-digital-twins-as-life-cycle-companions-11293
https://virtual.ispe.org/p/s/electron-beam-irradiation-of-liquids-in-biotech-and-pharma-11294
https://virtual.ispe.org/p/s/roundtable-discussion-11295
https://virtual.ispe.org/p/s/using-ai-to-streamline-manufacturing-and-cqv-process-11296
https://virtual.ispe.org/p/s/panel-discussion-11297
https://virtual.ispe.org/p/s/global-strategy-for-a-pandemic-vaccine-supply-11298
https://virtual.ispe.org/p/s/lunch-in-the-expo-hall-11299
https://virtual.ispe.org/p/s/api-lean-tactic-to-accelerate-process-commercialization-11300
https://virtual.ispe.org/p/s/next-generation-bioprocessing-facility-design-concepts-11301
https://virtual.ispe.org/p/s/core-digital-dp-knowledge-and-speed-to-commercialization-11302
https://virtual.ispe.org/p/s/oem-coordination-to-achieve-your-pharma-40-vision-11303
https://virtual.ispe.org/p/s/unified-knowledge-space-a-novel-lifecycle-enabler-11304
https://virtual.ispe.org/p/s/blank-slate-to-building-excellence-11305
https://virtual.ispe.org/p/s/coffee-break-11306
https://virtual.ispe.org/p/s/autogenerated-risk-profiles-to-accelerate-process-design-11307
https://virtual.ispe.org/p/s/biophorum-closure-playbook-and-filter-integrity-testing-11308
https://virtual.ispe.org/p/s/end-to-end-digital-twins-to-speed-up-commercialization-11309
https://virtual.ispe.org/p/s/facilities-for-large-scale-bacteriophage-manufacturing-11310
https://virtual.ispe.org/p/s/closing-remarks-11311
https://virtual.ispe.org/p/s/closing-remarks-11312
https://virtual.ispe.org/p/s/regulatory-challenges-for-a-machine-learning-solution-11323
https://virtual.ispe.org/p/cf/2024-ispe-pharma-40-and-annex-1-conference-11462
https://virtual.ispe.org/p/s/welcome-to-the-2024-ispe-pharma-40-and-annex-1-conference-11466
https://virtual.ispe.org/p/s/evolution-of-bio-manufacturing-and-outlook-to-the-future-11467
https://virtual.ispe.org/p/s/scaling-to-serve-more-patients-11468
https://virtual.ispe.org/p/s/message-from-the-conference-chairs-11469
https://virtual.ispe.org/p/s/a-word-from-the-ispe-foundation-11471
https://virtual.ispe.org/p/s/equipping-people-who-accelerate-pharma-40-transformation-11472
https://virtual.ispe.org/p/s/understanding-digitalization-and-its-potential-in-pharma-40-11473
https://virtual.ispe.org/p/s/is-closed-processing-for-atmps-at-risk-11475
https://virtual.ispe.org/p/s/planning-for-the-future-with-pharma-40-in-a-greenfield-11476
https://virtual.ispe.org/p/s/digital-atmp-setup-roadmap-insights-and-key-lessons-11477
https://virtual.ispe.org/p/s/the-journey-towards-a-lights-out-operation-11478
https://virtual.ispe.org/p/s/global-digitalization-of-contamination-control-system-11479
https://virtual.ispe.org/p/s/bridging-innovation-and-compliance-11480
https://virtual.ispe.org/p/s/implementation-of-eu-gmp-annex1-requirements-11482
https://virtual.ispe.org/p/s/continuous-api-pharma-40-factory-by-design-11483
https://virtual.ispe.org/p/s/using-raman-spectroscopy-in-mrna-manufacturing-11484
https://virtual.ispe.org/p/s/flexible-biomanufacturing-in-pharma-40-11485
https://virtual.ispe.org/p/s/conversations-on-annex-1-and-atmps-qbd-and-modular-manufacture-11486
https://virtual.ispe.org/p/s/supply-chain-solution-via-cloud-based-analytics-and-nir-scan-11487
https://virtual.ispe.org/p/s/message-from-the-ispe-italy-affiliate-11489
https://virtual.ispe.org/p/s/pioneering-change-women-in-pharma-r-panel-11490
https://virtual.ispe.org/p/s/set-up-of-a-ccs-using-the-haccp-methodology-11492
https://virtual.ispe.org/p/s/implementing-a-corporate-manufacturing-data-platform-11493
https://virtual.ispe.org/p/s/assessing-and-ensuring-annex-1-compliance-11494
https://virtual.ispe.org/p/s/global-industrial-data-hub-for-pharma-40-manufacturing-11495
https://virtual.ispe.org/p/s/data-centric-architectures-11496
https://virtual.ispe.org/p/s/augment-ops-while-building-in-quality-a-case-study-11497
https://virtual.ispe.org/p/s/robot-telemanipulation-removing-direct-human-contact-11499
https://virtual.ispe.org/p/s/speeding-up-and-simplifying-modular-equipment-connectivity-11500
https://virtual.ispe.org/p/s/a-better-approach-to-freeze-drying-process-aps-11501
https://virtual.ispe.org/p/s/ai-driven-high-throughput-catalyst-screening-11502
https://virtual.ispe.org/p/s/impact-annex-1-on-radio-ligand-therapy-production-11503
https://virtual.ispe.org/p/s/digitalized-batch-release-11504
https://virtual.ispe.org/p/s/8th-annual-pharma-40-survey-11506
https://virtual.ispe.org/p/s/closing-remarks-11507
https://virtual.ispe.org/p/s/data-management-requirements-for-sterile-manufacturing-11522
https://virtual.ispe.org/p/s/welcome-remarks-11523
https://virtual.ispe.org/p/s/considerations-regarding-pharmaceutical-process-models-11524
https://virtual.ispe.org/p/s/innovation-and-digitalization-in-manufacturing-the-quality-innovation-group-qig-11534
https://virtual.ispe.org/p/cf/2025-ispe-facilities-of-the-future-conference-11535
https://virtual.ispe.org/p/s/ses0-dummy-11536
https://virtual.ispe.org/p/s/accelerating-facility-delivery-through-standard-design-11537
https://virtual.ispe.org/p/s/managing-emerging-risks-from-pfas-legislations-11538
https://virtual.ispe.org/p/s/lyophilization-impact-on-annex-1-11539
https://virtual.ispe.org/p/s/solvent-and-reagent-in-situ-reuse-11540
https://virtual.ispe.org/p/s/case-study-a-future-ready-facility-in-record-time-11541
https://virtual.ispe.org/p/s/plastic-waste-quantitation-in-biopharmceutical-manufacturing-11542
https://virtual.ispe.org/p/s/a-new-standard-for-designing-agile-manufacturing-facilities-11543
https://virtual.ispe.org/p/s/practically-applicable-measures-to-save-energy-in-cleanroom-11544
https://virtual.ispe.org/p/s/navigating-radiopharmaceutical-facility-design-11545
https://virtual.ispe.org/p/s/reducing-the-carbon-footprint-of-cleanroom-environments-11546
https://virtual.ispe.org/p/s/adapting-a-mabs-production-facility-for-production-of-a-gene-therapy-11547
https://virtual.ispe.org/p/s/solutions-to-curb-manufacturing-emissions-11548
https://virtual.ispe.org/p/s/secrets-in-the-digital-transformation-vibe-11549
https://virtual.ispe.org/p/s/executive-forum-dinner-and-panel-discussion-11550
https://virtual.ispe.org/p/s/unlock-the-future-robot-telemanipulation-11551
https://virtual.ispe.org/p/s/unlock-flexibility-and-digitalization-with-modular-automation-11552
https://virtual.ispe.org/p/s/robotics-as-an-enabler-for-higher-regulatory-compliance-11553
https://virtual.ispe.org/p/s/implementing-data-driven-innovation-technology-strategy-11554
https://virtual.ispe.org/p/s/innovation-in-pharmaceutical-manufacturing-11555
https://virtual.ispe.org/p/s/accelerating-greenfield-project-with-ai-driven-process-11556
https://virtual.ispe.org/p/s/tomorrows-modular-frameworks-for-advanced-manufacturing-11557
https://virtual.ispe.org/p/s/the-journey-to-future-proofing-a-qc-lab-11558
https://virtual.ispe.org/p/s/2024-foya-overall-winner-eli-lilly-kinsale-limited-11559
https://virtual.ispe.org/p/s/creating-value-with-digital-twins-for-batch-plants-11560
https://virtual.ispe.org/p/s/innovation-districts-as-talent-ecosystems-11561
https://virtual.ispe.org/p/s/welcome-to-the-2025-ispe-facilities-of-the-future-conference-11570
https://virtual.ispe.org/p/s/mobilizing-a-digital-engineering-program-practitioner-view-11571
https://virtual.ispe.org/p/s/biopharmaceuticals-at-40-what-does-the-future-bring-11572
https://virtual.ispe.org/p/s/conference-highlights-11573
https://virtual.ispe.org/p/s/day-2-opening-remarks-11574
https://virtual.ispe.org/p/s/reaching-new-summits-in-pharmaceutical-manufacturing-11575
https://virtual.ispe.org/p/s/facilities-of-the-future-going-forward-11576
https://virtual.ispe.org/p/s/a-word-from-the-ispe-foundation-11577
https://virtual.ispe.org/p/s/message-from-the-san-franciscobay-area-chapter-11578
https://virtual.ispe.org/p/s/2025-facility-of-the-year-award-foya-submission-finalists-11579
https://virtual.ispe.org/p/s/lillys-manufacturing-innovation-to-reach-more-patients-11580
https://virtual.ispe.org/p/s/closing-remarks-and-adjournment-11581
https://virtual.ispe.org/p/s/case-study-software-applications-for-capacity-analysis-11582
https://virtual.ispe.org/p/cf/2025-ispe-aseptic-conference-11583
https://virtual.ispe.org/p/s/aseptic101-11586
https://virtual.ispe.org/p/s/welcome-to-the-2025-aseptic-conference-11587
https://virtual.ispe.org/p/s/thinking-outside-the-vial-manufacturing-organs-11588
https://virtual.ispe.org/p/s/keynote-presentation-11589
https://virtual.ispe.org/p/s/message-from-the-conference-chair-11590
https://virtual.ispe.org/p/s/navigating-annex-1-compliance-strategies-and-learnings-11591
https://virtual.ispe.org/p/s/annex-1-implementation-and-continuous-improvement-11592
https://virtual.ispe.org/p/s/deep-learning-impact-in-parenterals-inspection-11593
https://virtual.ispe.org/p/s/navigating-adcs-risk-regulatory-and-containment-11594
https://virtual.ispe.org/p/s/case-study-a-new-benchmark-for-aseptic-manufacturing-11595
https://virtual.ispe.org/p/s/automated-visual-inspection-process-and-transfer-11596
https://virtual.ispe.org/p/s/design-of-a-flexible-filling-line-for-multi-site-deployment-11597
https://virtual.ispe.org/p/s/case-study-syringe-and-cartridge-fill-finish-production-11598
https://virtual.ispe.org/p/s/automatic-visual-inspection-of-parenterals-hard-lessons-11599
https://virtual.ispe.org/p/s/isolator-filling-line-11600
https://virtual.ispe.org/p/s/transfer-of-ready-to-use-pack-styles-into-grade-a-11601
https://virtual.ispe.org/p/s/package-integrity-a-sensitive-dye-ingress-application-11602
https://virtual.ispe.org/p/s/case-study-moving-from-a-rabs-to-an-isolator-11603
https://virtual.ispe.org/p/s/reducing-glove-interventions-challenges-and-benefits-11604
https://virtual.ispe.org/p/s/sterility-testing-in-cell-and-tissue-therapies-11605
https://virtual.ispe.org/p/s/advanced-aseptic-fill-technology-case-study-and-future-11606
https://virtual.ispe.org/p/s/advanced-solutions-for-aseptic-material-transfer-11607
https://virtual.ispe.org/p/s/atp-based-alternative-microbial-methods-11608
https://virtual.ispe.org/p/s/fireside-chat-annex-1-experiences-11609
https://virtual.ispe.org/p/s/conference-highlights-11610
https://virtual.ispe.org/p/s/message-from-the-local-ispe-chapter-11611
https://virtual.ispe.org/p/s/the-new-wave-for-radiopharmaceuticals-11612
https://virtual.ispe.org/p/s/scaling-parenteral-manufacturing-from-design-to-operational-excellence-11613
https://virtual.ispe.org/p/s/message-from-the-ispe-foundation-11614
https://virtual.ispe.org/p/s/protecting-patients-resiliency-in-cell-therapy-11615
https://virtual.ispe.org/p/s/iso14644-7-separative-devices-coming-standard-update-11616
https://virtual.ispe.org/p/s/theoretical-analysis-of-ultrasonic-aerosol-dispersion-11617
https://virtual.ispe.org/p/s/opportunistic-approach-to-the-advanced-therapy-lifecycle-11618
https://virtual.ispe.org/p/s/ccs-sterilization-validation-of-critical-equipment-11619
https://virtual.ispe.org/p/s/integrated-vhp-technology-for-production-zonesrabs-11620
https://virtual.ispe.org/p/s/rft-design-enhancing-atmp-manufacturing-efficiency-11621
https://virtual.ispe.org/p/s/contamination-control-strategy-in-novo-nordisk-11622
https://virtual.ispe.org/p/s/can-we-in-situ-sip-indirect-contact-items-bowlslanes-11623
https://virtual.ispe.org/p/s/designing-radiopharmaceutical-production-facilities-11624
https://virtual.ispe.org/p/s/developing-a-ccs-for-atmp-cleanrooms-11625
https://virtual.ispe.org/p/s/case-study-aseptic-powder-dosing-meeting-annex-1-11626
https://virtual.ispe.org/p/s/balancing-radiation-safety-and-efficiency-in-radiopharma-11627
https://virtual.ispe.org/p/s/the-ins-and-outs-of-isolators-for-cell-therapies-11628
https://virtual.ispe.org/p/s/effective-sterile-powder-transfer-for-parenteral-dps-11629
https://virtual.ispe.org/p/s/radiopharmaceutical-aspects-of-aseptic-process-design-11630
https://virtual.ispe.org/p/s/realization-of-aseptic-industrial-atmp-manufacturing-11631
https://virtual.ispe.org/p/s/sus-sustainability-sterilization-unavoidable-particles-11632
https://virtual.ispe.org/p/s/general-session-11633
https://virtual.ispe.org/p/s/industry-panel-challenges-of-new-modalities-radiopharmaceuticals-cell-and-gene-therapies-and-antibody-drug-conjugates-11634